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ABSTRACT 
MECHANISMS FOR THE POTASSIUM-SPARING EFFECTS OF 
FUROSEMIDE IN MICE ON HIGH POTASSIUM DIETS 
Bangchen Wang, Ph.D. 
University of Nebraska Medical Center, 2018 
Supervisor: Steven C. Sansom, Ph.D. 
 
Because of its cardio-protective benefits, diets that are low in Na+ and high in K+ are 
often warranted in conjunction with use of diuretics such as furosemide for treating hypertension. 
It is critical to understand how such diets influence the diuretic actions on renal K+ handling in 
order to choose the best drug for patients. 
Furosemide is a commonly used K-wasting diuretic. It increases urinary K+ excretion by 
increasing distal Na+ delivery that stimulates K+ secretion. However, in wild-type mice (WT) 
adapted to an alkaline low Na+ high K+ diet (LNaHK), both 12-hour IP furosemide injection and 
7-day furosemide water treatment decreased renal K+ clearance. We hypothesized that there is 
furosemide-sensitive net K+ secretion in WT adapted to LNaHK. Free-flow micropuncture 
experiments showed that furosemide increased [K+] in the early distal tubule (EDT [K+]) in WT 
on a regular diet (RD) but decreased EDT [K+] in WT on LNaHK. Furosemide did not affect 
EDT [K+] in ROMK knockout mice (ROMK KO) on LNaHK or WT on an alkaline normal Na+ 
high K+ diet (HK). Furosemide-sensitive Na+ excretion was significantly greater in mice on 
LNaHK than those on RD or HK. Patch clamp analysis of split-open thick ascending limbs (TAL) 
revealed that the 70-pS ROMK channel exhibited a higher open probability (Po) but similar 
density in WT on LNaHK, compared to WT on RD. These results indicate that mice adapted to 
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LNaHK exhibit furosemide-sensitive net K+ secretion in the TAL that is dependent on increased 
NKCC2 activity and mediated by ROMK channels. 
Furosemide acidifies the urine by increasing acid secretion via the Na+-H+ exchanger 3 
(NHE3) in TAL and vacuolar H+-ATPase (V-ATPase) in the distal nephron. Because alkaline 
urine is required for BK-αβ4-mediated K+ secretion, we hypothesized that furosemide reduces 
BK-αβ4-mediated K+ secretion by acidifying the urine. Furosemide water treatment for 11 days 
led to decreased urine pH in both WT and BK-β4 knockout mice (BK-β4 KO) with increased V-
ATPase expression and elevated plasma aldosterone levels. However, furosemide water 
decreased renal K+ clearance and elevated plasma [K+] in WT but not BK-β4 KO. Addition of 
acetazolamide in furosemide water restored urine pH along with renal K+ clearance and plasma 
[K+] to similar levels as control group. Additionally, western blotting and immunofluorescence 
staining showed that furosemide decreased cortical expression of BK-β4 and reduced apical 
localization of BK-α in connecting tubules (CNT); they were restored by adding acetazolamide to 
furosemide water. These results indicate that in mice adapted to HK, furosemide reduces BK-
αβ4-mediated K+ secretion by acidifying the urine. 
In conclusion, by inhibiting net K+ secretion in the TAL and BK-αβ4-mediated K+ 
secretion in CNT, furosemide acts as a K-sparing diuretic in mice adapted to LNaHK and HK. 
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INTRODUCTION 
Health benefits of high potassium diets 
 For tens of thousands of years, humans have been hunter-gatherers and consumed an 
ancient diet that is rich in fruits and vegetables with low sodium (Na) and high potassium (K). In 
the past 200 years since the industrial evolution, modern humans, especially in the western 
culture, have switched to the modern western diet, which contains abundant processed food but 
few fruits and vegetables with high Na+ and low K (1). The high Na+ low K+ modern diet has 
long been known for its association with cardiovascular diseases including hypertension and 
stroke (2, 3). The FDA-recommended daily intake in adults is less than 2300 mg/day for Na+ and 
at least 4700 mg/day for K. Unfortunately, according to data from the National Health and 
Nutrition Examination Survey (NHANES), most US adults exceed the recommended Na+ intake 
with an average of 3600 mg/day and only 2800 mg/day K+ intake (4, 5).  
 The most extensively studied of dietary impacts on cardiovascular diseases are the DASH 
(Dietary Approaches to Stop Hypertension) diet studies. In one study, 412 subjects, with an 
average blood pressure of 135/86 mmHg and without antihypertensive treatments, were given 
either the control diet or the DASH diet that is rich in fruits, vegetables, and low-fat dairy 
products with three different levels of Na+ intake: low at 50 mmol/day (2.2 g/day), intermediate at 
100 mmol/day (4.3 g/day), and high at 150 mmol/day (6.5 g/day). The K+ intake was 
approximately 40 mmol/day (1 g/day) for control group and 80 mmol/day (2 g/day) for DASH 
group. When compared to those on the control diet, subjects on DASH diet had lower blood 
pressure at each Na+ intake level, with the lowest blood pressure in the low Na+ DASH group (6).  
Other widely promoted healthy diets include Mediterranean, Paleolithic, and vegetarian 
diets. They all emphasize the consumption of fruits and vegetables and contain higher K+ and 
lower Na+ contents than the western diet. They have been associated with lower risks for 
2 
 
cardiovascular diseases, cancer and overall mortality (7-12). The Paleolithic diet best mimics the 
diet consumed by ancient humans for tens of thousands of years as hunter-gatherers. From studies 
of over 50 hunter-gatherer societies, Eaton SB et. al. (13) estimated the daily Na+ and K+ intake 
of ancient humans. Table 1 clearly demonstrates the large difference in Na+ and K+ contents 
between the Paleolithic hunter-gatherer and modern western diets. Furthermore, the study on the 
Yanomami tribe (14) showed an even more strikingly high K/Na+ intake ratio with an average 
blood pressure of 100/60 mmHg.  
Another important aspect of the high K+ diets is the alkalinity. Many high K+ foods 
including fruits, vegetables and legumes are naturally alkaline. The large difference between 
urinary K+ and Cl- excretion in the Yanomami people suggests the highly alkaline nature of their 
diet (Table 1). In stroke-prone spontaneously hypertensive rat, supplemental KHCO3 or K+ 
citrate attenuated hypertension compared to control; while supplemental KCl exacerbated 
hypertension and increased stroke risk (1, 15, 16).  The studies of supplemental KHCO3/citrate vs 
KCl in humans, however, did not show an effect on blood pressure (17-19). 
Nonetheless, the benefits of high K+ diets as well as K+ supplements have been strongly 
supported by numerous studies. Therefore, it is critical to understand how the body maintains K+ 
homeostasis with the excess K+ intake. 
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Table 1. Daily urinary Na+ and K+ excretion of different diets. 
Diet Na+ (mmol/day) K (mmol/day) 
K/Na+ 
ratio 
Cl (mmol/day) 
FDA Guideline 100 120 1.2 N/A 
Modern (5) 157 72 0.5 N/A 
DASH (low Na) (6) 65 82 1.3 N/A 
Paleolithic (13) 30 282 9.3 N/A 
Yanomami (14) 1 152 152 13.7 
N/A, not available 
  
4 
 
Normal K+ homeostasis in the body 
 The plasma [K+] has to be tightly controlled within the range of 3.5 – 5.0 mM. Both 
hypokalemia and hyperkalemia may lead to dysfunctions in muscles, kidneys and especially the 
heart. In a healthy person, the entire daily intake of K+ is excreted, 90% in urine and 10% in 
stools. Compared to the 100 mmol daily K+ intake and 65 mmol extracellular K+, 3300 mmol K+ 
is stored in the intracellular compartment, mainly in muscle cells (Figure 1). In addition to renal 
excretion, this large pool of intracellular K+ plays a critical role in quickly adjusting plasma [K+] 
to prevent hyperkalemia during an acute K+ intake. K+ is shifted into the cells by the Na+-K+-
ATPase (NKA) that pumps 2 K+ in and 3 Na+ out of the cell.  
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Figure 1. Normal K+ balance in the body (modified from Wingo CS, et. al. 2000) (20). 
K+ in the body is balanced between the small extracellular pool (~65 mEq) and the large intracellular pool 
(~3300 mEq). K+ is actively pumped into the cells by NKA. In equilibrium, the daily K+ intake (~100 
mEq/day) is completely excreted by the kidneys (90 – 95 mEq/day) and the colon (5 – 10 mEq/day). 
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Kidneys play the essential role to maintain K+ balance in the long term. Under normal 
conditions, K+ in blood is freely filtered into the glomerulus. Most of filtered K+ is reabsorbed by 
the proximal tubule (PT) and the thick ascending limb (TAL) of the loop of Henle, following Na+ 
reabsorption. In the aldosterone-sensitive distal nephron (ASDN), which consists of distal 
convoluted tubule 2 (DCT2), connecting tubule (CNT), and cortical collecting duct (CCD), K+ is 
secreted into the tubular lumen (Figure 2) (21). This distal K+ secretion is driven by the negative 
lumen potential generated by Na+ reabsorption via epithelial Na+ channel (ENaC) and is mediated 
by two K+ channels, renal outer medullary K+ (ROMK) channels in principal cells and large 
conductance Ca2+-activated K+ (BK) channels in both principal cells and intercalated cells. The 
ROMK channel is considered constitutively active and mediates K+ secretion under basal 
conditions, i. e. regular diets (regular rodent chow) (22, 23). The BK channel, however, has a 
minimal role under regular diets. It is activated by high urinary flows under high K+ dietary 
conditions (24). Given the high K+ nature of the ancient diets, the BK channel is considered to be 
the ancient K+ channel (25). Deletion of either channel is compensated by the overexpression of 
the other (26, 27). The two K+ channels are regulated differently and work together to safeguard 
against the life-threatening hyperkalemia (25).  
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Figure 2. K+ transport in the nephron.  
K+ is freely filtered into the glomerulus. Approximately 2/3 of filtered K+ is reabsorbed in the PT following 
Na+ and water reabsorption. Approximately 20% is reabsorbed in the TAL by Na+-K+-2Cl- cotransporter 2 
(NKCC2). K+ is secreted into the lumen of the ASDN (consisting of DCT2, CNT, and CCD), driven by the 
negative lumen potential generated by Na+ reabsorption via ENaC.  
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Structure, localization and function of ROMK channels in the kidney 
ROMK (a.k.a. Kir1.1 or KCNJ1) is a member of the KCNJ family (potassium inwardly-
rectifying channel, subfamily J) that is characterized by a larger inward current than outward 
current (22). They have two transmembrane domains, a K+ selectivity filter, and cytoplasmic N- 
and C- terminal domains (Figure 3). Kir channels (inwardly-rectifying K+ channels) are 
constructed by four homomeric or heteromeric subunits, forming a pore in the center (28). In the 
kidney, ROMK channels are localized in the apical membrane of the TAL as well as the principal 
cells of ASDN. Differing from other members in the family, ROMK channels are only weakly 
inwardly-rectifying with a high basal open probability and mediates K+ secretion into the tubular 
lumen (22).  
Patch clamp studies have found an apical 30-pS Kir channel in the CCD and both a 30-pS 
and a 70-pS Kir channel in the TAL (29-32). Several lines of evidence indicate that these 
secretory K+ channels were ROMK channels. First, immunostaining found ROMK expressed in 
these nephron segments (33-35). Secondly, expression of ROMK in Xenopus oocytes exhibited 
indistinguishable biophysical and pharmacological properties compared to the secretory 30-pS 
Kir channel (22, 23, 36). Finally, the 30-pS and 70-pS Kir channels were not found in the TAL 
and CCD of ROMK knockout mice (37).  
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Figure 3. ROMK structure and isoform expression along the nephron (modified from Welling and 
Ho, 2009) (28).  
A. ROMK consists of two transmembrane domains, a K+ selectivity filter, and cytoplasmic N- and C- 
terminal domains. B. ROMK has three different splicing variants. ROMK1 is expressed in the CNT and 
CD. ROMK2 is expressed in the TAL, DCT, CNT, and CCD. ROMK3 is expressed in the TAL and DCT. 
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ROMK channels play different roles in the TAL vs ASDN (Figure 4). In the TAL, 
ROMK is required for recycling K+ back into the lumen in order to maintain NaCl reabsorption 
via Na+-K+-2Cl- cotransporter 2 (NKCC2). Mutations in ROMK cause the type 2 Bartter 
Syndrome, which presents with maternal polyhydramnios, premature delivery, polyuria, 
polydipsia, volume depletion, transient hyperkalemic acidosis and later hypokalemia (38, 39). 
Consistently, ROMK knockout mice also exhibit a similar phenotype with high neonatal 
mortality and severe volume depletion with impaired NaCl reabsorption in TAL (40). In the 
ASDN, however, ROMK channels mainly serve to secrete K+ in a well-regulated fashion to 
maintain K+ balance in the body (41, 42). The different roles of ROMK channels in different 
nephron segments may have to do with the differential expressions of ROMK isoforms (Figure 
3) (28). ROMK2 and ROMK3 are expressed in the TAL; while ROMK1 and ROMK2 are 
expressed in the ASDN. A recent study showed that ROMK1 deletion impaired ROMK 
regulation by high K+ diets in the ASDN without affecting NaCl reabsorption in the TAL (43).  
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Figure 4. Role of ROMK in the TAL and ASDN (modified from Welling and Ho, 2009) (28).  
ROMK channels play different roles in the TAL and ASDN. In the TAL, ROMK encodes for the 30-pS and 
70-pS K+ secretory channels in the apical membrane, which are required for the recycling of K+ reabsorbed 
by NKCC2 to maintain NaCl reabsorption. The NKCC2 transport is powered by NKA in the basolateral 
membrane. In the ASDN, ROMK encodes for the 30-pS K+ secretory channel in the apical membrane. The 
K+ secretion is driven by the negative lumen potential generated by Na+ reabsorption via ENaC. They are 
also powered by NKA in the basolateral membrane. 
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Structure, localization and function of BK channels in the kidney 
BK channels (also called Maxi-K, KCa1.1 or SLO1) are large conductance (150 – 250 
pS), voltage-gated, Ca2+-activated K+ channels. The BK channel consists of four pore-forming α 
subunits, encoded by the Kcnma1 gene, and one of the four different accessory β subunits (β1 – 
β4), encoded by the Kcnmb1-4 genes. The α-subunit consists of seven transmembrane domains 
and a large cytosolic C-terminal domain (Figure 5) (44-46). As a unique part of the BK channel, 
the S0 segment is required for the modulation by β subunits (47, 48). The S1-S4 segments form 
the voltage sensor; S5 and S6 segments form the pore and selectivity filter (49). The C-terminal 
domain of BK-α contains two regulators of K+ conductance (RCK) domains. The RCK1 contains 
a Ca2+ and a Mg2+ binding site, while the RCK2 contains another Ca2+ binding site in a region 
termed as the Ca2+ bowl. These sites are responsible for BK channel activation by Ca2+ and Mg2+ 
(50, 51). Each β subunit of BK has two transmembrane domains connected by a large extracellular 
loop (Figure 5). The four β subunits exert different and complex effects on the BK channel, 
including modulations of voltage and Ca2+ sensitivities, pharmacokinetics, and protein trafficking 
(52-58). Recently, four γ subunits of BK were discovered, and they seem to regulate BK channels 
in a similar manner as the β subunits (45, 59-61). BK channels are expressed in a wide variety of 
tissues and play important roles in various physiological processes including smooth muscle 
contractility, neuronal excitability, and hair cell tuning (62-68). The diverse functions of BK 
channels may be explained by the alternative splicing of the α subunit and modulations by tissue-
specific β subunits (45, 69-71).  
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Figure 5. Structure of the α and β subunits of BK (modified from Zhang J. et. al. 2014) (45).  
BK-α subunit consists of seven transmembrane domains and a large cytosolic C-terminal domain. The BK-
β subunit consists of two transmembrane domains and a large extracellular loop. 
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In the kidney, BK channels are also expressed in a variety of cell types, including renal 
vascular smooth muscle cells, podocytes, mesangial cells, and tubular epithelial cells. In the 
afferent arterioles, BK channels had modest tonic dilator effects (72). In podocytes and mesangial 
cells, BK channels regulate mesangial contractility and glomerular filtration rate (GFR) (73, 74). 
In renal tubules, BK channels have been found in the TAL (75, 76), DCT (77), CNT (78-80), and 
CD (24, 81-83). High luminal fluid flow has been long known to stimulate distal K+ secretion. 
Traditionally, high flow was thought to stimulate K+ secretion by rapidly flushing tubular fluid 
downstream to maintain the chemical gradient for K+ secretion (84). However, studies by Woda 
et. al. (24, 80) were the first to identify the BK channel as the main player in the flow-induced K+ 
secretion (FIKS) in the CNT and CCD. This was further confirmed by genetic deletion of BK-α, 
where vasopressin blockade caused no change in K+ excretion in BK-α knockout mice despite a 
profound increase in urinary flow (27).  
Among the four BK-β subunits, BK-β1, β2, and β4 are expressed in mouse kidneys (85). 
BK-β1 is expressed in principal cells of mouse CNT (79, 85) and rabbit CNT and CCD (79, 86). 
BK-β1 knockout mice had attenuated kaliuretic response to volume expansion (79, 87). On high 
K+ diets (HK), BK-β1 knockout exhibited elevated plasma [K+], reduced K+ clearance and 
exacerbated hypertension due to elevated aldosterone (88). BK-β4 is expressed in the TAL, DCT 
and intercalated cells of CNT and CD (85). BK-β4 was found to protect BK-α from lysosomal 
degradation (58). On HK, BK-β4 knockout mice presented with elevated plasma [K+] and 
reduced K+ clearance, which may be due to decreased apical localization of BK-α or attenuated 
intercalated cell size reduction in response to HK diets (58, 89, 90). Most recently, the study by 
Larsen et. al.  (91) found that BK-β2 knockout mice displayed normal plasma [K+] and urinary K+ 
excretion with elevated plasma aldosterone on both regular diets (RD) and HK diets. This 
indicates that BK-αβ1 and BK-αβ4 channels are the major players in BK-mediated K+ secretion. 
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The exact mechanism of how flow activates BK channels remains an area of great 
interest. High tubular fluid flow causes increases in intracellular [Ca2+], which can activate BK 
channels (92). However, the Ca2+ current is only transient and cannot sustain BK activation. 
Recent studies have discovered that paracrine and autocrine factors such as ATP and 
prostaglandin E2 (PGE2) may stimulate signaling pathways to sustain BK activity (93-95). 
Furthermore, the primary cilium of principal cells may serve as the mechanosensor for tubular 
fluid flow (96). According to the model shown in Figure 6 (97), high luminal fluid flow bends 
the primary cilium on principal cells, driving Ca2+ entry through the transient receptor potential 
vanilloid 4 (TRPV4) channels (98), stimulating Ca2+ release from intracellular Ca2+ stores, 
activating BK-αβ1 channels in principal cells (92). The sustained activation of BK-αβ1 in 
principal cells and BK-αβ4 in intercalated cells may be achieved via paracrine and autocrine 
signaling of PGE2 and ATP (93-95).  
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Figure 6. Flow-dependent activation of BK channels (modified from Welling, 2016) (97).  
High flow bends the primary cilium on principal cells, driving Ca2+ entry via the TRPV4 channel, 
stimulating Ca2+ release from intracellular storage, activating BK-αβ1 channels in principal cells. The 
sustained activation of BK-αβ1 channels in principal cells and BK-αβ4 channels in intercalated cells occur 
indirectly through paracrine signaling of PGE2 and autocrine signaling of ATP. Abbreviations: MAPK, 
mitogen-activated protein kinases; ERK, extracellular signal regulated kinase; PGE2, prostaglandin E2; 
PKA, protein kinase A; V-ATPase, vacuolar-H+ ATPase; AE4, Anion Exchanger 4. 
  
17 
 
Renal K+ handling on high K+ diets 
Kidneys can quickly adapt to excrete high K+ intake by increasing K+ secretion through 
ROMK and BK channels in the ASDN. As indicated by the name of the nephron segment, 
aldosterone is a major regulator of K+ excretion in the aldosterone-sensitive distal nephron 
(ASDN). In mice fed on a high K+ diet, plasma aldosterone levels reaches to approximately 750 
pg/mL from 240 pg/mL on a regular diet (99). Aldosterone has various actions in the ASDN to 
stimulate urinary K+ excretion. In the principal cells, aldosterone upregulates ENaC expression 
and activity to increase Na+ reabsorption (100, 101), increasing the driving force for K+ secretion 
via both ROMK and BK channels. It also upregulates the activity of the NKA in the basolateral 
membrane to facilitate Na+ reabsorption and K+ secretion (102). Additionally, aldosterone can 
increase the forward trafficking of ROMK channels to increase channel expressions in the apical 
membrane (42, 103). Furthermore, aldosterone upregulates BK-α expression in the intercalated 
cells (58) and TRPV4 expression in both principal cells and intercalated cells (104) to facilitate 
BK channel activation and K+ secretion. Interestingly, under the condition of LNaHK, plasma 
aldosterone is elevated to approximately 3600 pg/mL, 15 times higher than the basal level. It 
seems that this elevation is necessary to generate a high rate of BK-α/β4-mediated K+ secretion, 
creating an osmotic diuresis to maintain K+ homeostasis (99).  
Besides aldosterone, other factors also contribute to maintain K+ balance under HK and 
LNaHK conditions. Recent studies showed that elevated plasma [K+] itself could increase 
kaliuresis by inhibiting Kir4.1/5.1 channels in the basolateral membrane of DCT1, depolarizing 
the cell membrane and blocking Cl- exit (105). The increased intracellular [Cl-] inhibits the With-
no-lysine 4 (WNK4) kinase and reduces the phosphorylation and activity of the Na+-Cl- 
cotransporter (NCC) in DCT (105). The inhibition of NCC causes increased Na+ delivery and 
increased tubular fluid flow to the distal nephron, increasing distal K+ secretion through both 
ROMK and BK channels.  
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Recent studies indicate that the alkalinity of HK diets plays a critical role in renal K+ 
handling. Mice fed an alkaline HK or LNaHK diet maintain their plasma [K+] below 5.0 mM (58, 
90, 99). However, mice fed high KCl (HKCl) or low Na+ high KCl diets (LNaHKCl) have 
substantial hyperkalemia with plasma [K+] above 6.5 mM (58, 90, 99). The intolerance of HKCl 
results from the lack of BK-αβ4-mediated K+ secretion which is only active under alkaline 
conditions (90). Therefore, BK-αβ4 channels are required for increasing urinary K+ excretion and 
maintaining plasma [K+] on alkaline HK and LNaHK diets (58, 90). For simplicity, in the rest of 
this dissertation, HK and LNaHK will refer to the alkaline diets unless otherwise noted. 
Dietary influences on the actions of diuretics 
Diuretic drugs are very commonly used for treating many diseases such as hypertension, 
heart failure, and edema. The CDC estimates that more than 20% of all people over the age of 65 
are taking diuretics (106). The effects of diuretics have been extensively studied and well 
understood. In general, diuretics act on different segments of the nephron to inhibit Na+ 
reabsorption to induce diuresis (Figure 7). Diuretics that act on nephron segments proximal to 
ASDN, such as loop and thiazide diuretics, are K-wasting because they increase Na+ delivery to 
the ASDN and thus lead to increased distal K+ secretion. On the other hand, diuretics that act on 
ASDN such as amiloride and spironolactone are K-sparing because they inhibit Na+ reabsorption 
via ENaC and thus inhibit K+ secretion in the ASDN. 
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Figure 7. Diuretic sites of actions in the nephron (modified from Chaudhry S.) (107).  
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However, the actions of diuretics have been only studied in subjects eating modern diets. 
Little is known about how dietary K+ contents influence the effects of diuretics in humans. 
Animal studies provide useful insights into the effects of diuretics under high dietary K+ 
conditions. In mice adapted to HK diet, NCC activity is inhibited to shift Na+ reabsorption to 
ENaC in the ASDN in exchange for K+ secretion (105). As a result, on both HK and LNaHK 
diets, the effects of thiazide diuretics are greatly attenuated (108, 109); while the effects of K-
sparing diuretics such as amiloride and spironolactone are much enhanced (99, 109). In fact, mice 
on HK diet treated with amiloride or spironolactone exhibit profound hyperkalemia (109).  
Furosemide, commonly known as Lasix® or “water pill”, is one of the most commonly 
used diuretics. It is secreted by the proximal tubule into the lumen. From the luminal side, it 
blocks the Cl- binding site of NKCC2 in the TAL (110). This leads to a series of consequences. 
Furosemide inhibits NaCl reabsorption in the TAL, which usually reabsorbs 20% of filtered Na+, 
leading to profound natriuresis. The increased Na+ delivery to the ASDN creates a more negative 
lumen potential due to Na+ reabsorption by ENaC, causing increased K+ secretion and thus 
kaliuresis. Additionally, furosemide obliterates the medullary interstitial gradient, which is 
established by NaCl reabsorption in the TAL, reducing the urinary concentrating ability. 
Furthermore, furosemide inhibits the tubuloglomerular feedback by disrupting the Cl--sensing 
mechanism of the macula densa, which is mediated by NKCC2 (111-115). However, the 
furosemide-induced volume depletion can still activate the renin-angiotensin-aldosterone system 
(RAAS) probably by activation of sympathetic nervous system (116-118).  
The cardiovascular benefits of HK diets are at least partially attributed to their diuretic 
effects (17, 119, 120). Traditionally, this was thought to be due to the inhibition of NKCC2 in the 
TAL. Micropuncture experiments in Munich-Wistar rats that have exposed renal papilla showed 
that the medullary interstitial [K+] at vasa recta reached 46 mM due to medullary K+ recycling 
(121). The in vitro microperfusion experiments by Stokes et. al. (122) showed that, compared to 5 
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mM [K+], bath solutions with 25 mM [K+] inhibited the basolateral K+ channels in isolated 
medullary TAL. The consequent depolarization of the cell membrane blocked Cl- exit, thereby 
inhibiting the NKCC2-mediated NaCl reabsorption. However, there are a few flaws with this 
mechanism. Chronic K+ loading increased the interstitial [K+] from 32 mM to 46 mM in the vasa 
recta at the bend of the loop with an osmolality of 900 mOsm (121). This 44% increase was not 
well represented in the in vitro experiments, which compared the effects of 5 mM to 25 mM [K+] 
bath solutions. Additionally, the Munich-Wistar rats have renal developmental abnormalities, 
which allow for the loop measurement but may also differ from normally developed animals. 
Furthermore, the inhibition of fluid reabsorption in PT (123) as well as the recent discovery of 
plasma [K+] regulation of NCC in DCT (119) provides another explanation for the diuretic effect 
of HK diet. Overall, the effect of HK or LNaHK diet on the action of furosemide remains unclear.  
The studies in this dissertation seek to investigate how LNaHK and HK diet influence the 
effect of furosemide on renal K+ handling. 
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CHAPTER 1: NET K+ SECRETION IN THE THICK ASCENDING 
LIMB OF MICE ON AN ALKALINE LOW NA HIGH K+ DIET * 
Introduction 
In contrast to the modern Western diet that has high Na+ and low K+ contents, the 
“ancient” diets, such as the Paleolithic and Mediterranean diets, comprise a preponderance of 
fruits and vegetables and are low in Na+ and high in K. The ancient diets are well known for their 
health benefits in cardiovascular diseases, diabetes, obesity, and multiple cancers (7, 10, 124-
126). Our understanding of such diets has, in large part, derived from studies of the South 
American Yanomami, an isolated culture known for consuming a high K+ alkaline diet with 
nearly zero Na (14). Our lab has developed and studied the renal K+ handling of mice on LNaHK 
diet as an exaggeration of the ancient diet consumed by the Yanomami (90, 99, 127). Our 
understanding of the mechanism for handling LNaHK intake is crucial to choosing effective 
diuretics and preventing the drastic consequences of hypokalemia or hyperkalemia for patients on 
such diets (108). 
Potassium ions are freely filtered in the nephron and reabsorbed by the proximal tubule 
and the TAL. Potassium is secreted into the lumen in the ASDN by the ROMK and BK channels 
(25, 128). Potassium secretion is driven by the negative lumen potential generated by Na+ 
reabsorption through ENaC channel (42, 109). On HK diet, the medullary interstitial [K+] can 
reach 39-53 mM by medullary K+ recycling (121). The ex vivo microperfusion experiments by 
Stokes et. al. (122) showed that high medullary interstitial [K+] may inhibit NaCl reabsorption via 
NKCC2 and increase distal flow and Na+ delivery to stimulate K+ secretion in the distal nephron. 
This is a recognized cause for the diuretic effect of high K+ diets (42, 129). On the other hand, 
                                                          
* The materials presented in this chapter was previously published: Wang, B., Wen, D., Li, H., Wang-France, J. & 
Sansom, S. C. Net K(+) secretion in the thick ascending limb of mice on a low-Na, high-K diet. Kidney Int 92, 864-
875, 2017. 
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studies showed that NKCC2 activity is increased in mice on a low Na+ diet (130, 131). The 
dietary effect of both low Na+ and high K+ on the ion transport in the TAL remains uncertain. 
Ex vivo microperfusion studies showed that K+ was reabsorbed in the isolated perfused 
medullary TAL but secreted in the cortical TAL (132, 133). However, net K+ secretion in the 
TAL has not been shown in vivo, and the physiological conditions and implications of net K+ 
secretion in the TAL remain unclear. In the current study, we found that after mice were adapted 
to LNaHK diet, furosemide, an inhibitor of NKCC2, enhanced urinary Na+ and decreased urinary 
K+ excretion. Given the high interstitial [K+] generated by medullary K+ recycling, we 
hypothesized that, in mice fed a LNaHK diet, NKCC2 is still active with net K+ secretion in the 
TAL which can be inhibited by furosemide. 
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Methods 
Animals 
 All animals were maintained in accordance with the Institutional Animal Care and Use 
Committee of the University of Nebraska Medical Center. Wild-type mice on C57BL/6 
background (Charles River Laboratories, Wilmington, MA), ROMK wild-type and knockout 
littermates on 129/SvJ background (generously provided by Dr. Tong Wang, Yale University 
School of Medicine) were housed in the UNMC animal facility and maintained on a 12-hour day-
night cycle, with free access to water and food.  
Metabolic cage 
Wild-type mice, at 10–12 weeks of age, were given either regular mouse chow (RD; 
0.3% Na, 0.6% K), a high K+ diet (HK diet; 0.3% Na, 5% K with equimolar carbonate/citrate/Cl 
as anions; TD.07278; Envigo, Indianapolis, IN) or a low Na, high K+ diet (LNaHK diet; 0.01% 
Na, 5% K with equimolar carbonate/citrate/Cl as anions; TD.07278; Envigo, Indianapolis, IN) for 
4–7 days. Before experiments, mice were placed in metabolic cages for 1 day for acclimation. For 
acute diuretic treatments, mice were given intraperitoneal injections of vehicle (100 µL poly 
(ethylene glycol); PEG) or furosemide (15 mg/kg) and returned to metabolic cages for 12 hours to 
collect urine and measure food and water consumption. For chronic furosemide treatments, mice 
were provided either furosemide water (0.1 mg/mL, pH 8.4 with 0.7 mM K+) or control water 
(0.7 mM KHCO3, pH 8.4). Urine was collected in metabolic cages for 24 hours the day before 
treatment and on day 1, day 4, and day 7 after treatments. The mice were then anesthetized, 
sacrificed by exsanguination from the carotid artery, and blood and kidneys were collected. Urine 
and plasma osmolality were measured with an osmometer (Model 3250, Advanced Instruments, 
Norwood, MA). Urine and plasma Na+ and K+ concentrations were determined by a flame 
photometer (PFP7, Jenway, Burlington, NJ). 
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Micropuncture  
 A mixture of male and female wild-type and ROMK knockout mice at 10–12 weeks of 
age were given RD, LNaHK diet, or HK diet for 4–7 days. Micropuncture procedures were 
previously described (134). Briefly, mice were anesthetized with ketamine/xylazine cocktail and 
the left kidney was immobilized in a Lucite kidney cup (Vestavia Scientific, Atlanta, GA). 
Modified saline solution with FITC-inulin (140 mM NaCl, 5 mM KHCO3, 2% Mannitol, 500 
µg/mL FITC-inulin) was infused via left jugular vein at a rate of 0.5 mL/hr. Urine was collected 
under mineral oil through a bladder catheter. Blood pressure was monitored with a pressure 
transducer (Model 427488, Harvard Apparatus, Holliston, MA) via right common carotid artery. 
Distal tubules were identified by injecting proximal tubules with 0.5% Fast Green FCF (Sigma, 
St Louis, MO). Microelectrodes were made as previously described (134). A K+-selective 
microelectrode and a reference microelectrode were placed in the lumen of an early distal tubule 
(EDT). The voltage readings were recorded using a high impedance electrometer (Model FD223, 
World Precision Instruments, Hamden, CT) before and after an intravenous administration of 
furosemide (5 mg/kg in normal saline) via a separate catheter in left jugular vein. K+ 
concentrations were determined from calibration curves generated by standard solutions that 
minimize Na+ interference on measurements (55 mM NaCl with 2.5, 5, 10, or 20 mM KCl). 
Furosemide-sensitive UNaV̇ was calculated by subtracting UNaV̇ before furosemide treatment from 
UNaV̇ after furosemide treatment. 
GFR measurement 
 Glomerular filtration rate was measured using FITC-inulin (Sigma, St Louis, MO) during 
the micropuncture experiments as previously described (87). The mice were allowed to 
equilibrate for 1 hour after IV catheter placement. Urine was collected under mineral oil for 30 
minutes before and 20 minutes after furosemide administration. Approximately 20 µL blood was 
collected from carotid catheter at the midpoint of each clearance period. Urine flow was 
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determined gravimetrically, and the inulin concentration in urine and plasma were measured 
using a fluorescence microplate reader at 480 nm excitation and 520 nm emission. GFR was 
calculated for the periods before and after furosemide administration.  
Patch clamp  
Wild-type and ROMK knockout mice were provided either RD or LNaHK diet for 7 
days. The mice were anesthetized and sacrificed, and the kidneys were removed and cut in 
coronal sections. TALs were isolated and placed onto a 5 x 5 mm cover glass coated with Poly-L-
lysine (Sigma, St Louis, MO) in the bath solution (in mM: 140 NaCl, 5 KCl, 1.8 MgCl2, 1.8 
CaCl2, and 10 HEPES and pH 7.4). The cover glass was transferred to a plexiglass chamber on 
the stage of an inverted microscope (IX73, Olympus Corporation, Center Valley, PA). The 
tubules were split open by a sharpened micropipette to access the apical surface of TAL. Single-
channel patch clamping was performed as described previously (135, 136). Briefly, glass pipettes 
were pulled using a micropipette puller (P-97, Sutter Instruments, Novato, CA), polished and 
filled with the pipette solution (in mM: 140 KCl and 10 HEPES with pH 7.4 adjusted with KOH). 
Single-channel currents were amplified by the Axopatch 200B Amplifier (AutoMate Scientific, 
Berkeley, CA) and low-pass filtered at 200 Hz by the Low-pass Bessel (LPF-8, Warner 
Instruments, Hamden, CT). Signals were digitized at a sampling rate of 10 kHz by the Digidata 
1440A digitizer (Axon Instruments, Foster City, CA) and recorded and analyzed with pCLAMP 
10 software (Molecular Devices, Sunnyvale, CA). 
Immunofluorescence staining 
 Kidneys from sacrificed mice were placed in HistochoiceMB tissue fixative (Bioworld, 
Dublin, OH) for 24 hours, embedded in paraffin, and sectioned onto slides. Procedures for 
immunofluorescence staining were previously described (89). In short, slides were rinsed for 10 
min in xylene twice, and 2 min in 100%, 95%, 75%, 50%, 35% ethanol, and distilled water. 
Antigen retrieval was performed by microwaving slides in 0.01 M Na+ citrate solution at pH 6.0 
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for 15 min. Slides were then cooled to room temperature and rinsed in 0.1% PBS-Tween for 2 
min (3 times), blocked with 1% BSA in PBS for 30 min, and incubated with primary antibody 
overnight at 4 °C. The next day, slides were rinsed in PBS-T for 2 min (3 times) and incubated 
with secondary antibodies for 1 hour at room temperature. Slides were again rinsed in PBS-T for 
2 min (3 times) and mounted with EMS Shield Mount with DABCO (Electron Microscopy 
Sciences, Hatfield, PA). The following primary antibodies were used: ROMK (rabbit, diluted 
1:200, generous gift from Dr. Paul Welling, University of Maryland, Baltimore, MD), and THP 
(goat, diluted 1:200, Santa Cruz). The following secondary antibodies were applied for 1 hour: 
donkey anti-rabbit IgG conjugated Alexa Fluor 488 and donkey anti-goat IgG conjugated Alexa 
Fluor 594, diluted 1:200 (Invitrogen, Carlsbad, CA).  
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Results 
K+ secretion in the TAL with LNaHK diet 
 In traditional understanding, a high K+ diet inhibits NKCC2 in the TAL, causing its 
diuretic effect (122). We first examined the effect of furosemide in mice on either RD or LNaHK 
diet. On both regular diet (RD) and LNaHK diet, wild-type mice (WT) receiving IP furosemide 
exhibited significantly higher urinary Na+ clearance and lower urine osmolality than those treated 
with vehicle (Figure 8A, Table 2). Thus, Na+ is still actively reabsorbed via NKCC2 in mice on 
LNaHK diet.  
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Figure 8. Effect of furosemide on urinary Na+ and K+ clearances in mice on RD and LNaHK diet.  
A. Twelve-hour renal Na+ clearance of mice on RD or LNaHK diet treated with IP injections of vehicle or 
furosemide. B. Twelve-hour renal K+ clearance of mice on RD or LNaHK diet treated with IP injections of 
vehicle, furosemide, amiloride, or amiloride + furosemide. N = 4 – 14 per group. *p < 0.05 vs vehicle; #p < 
0.05 vs amiloride analyzed using two-way ANOVA with a post-hoc Tukey test. 
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Table 2. Metabolic cage measurements for 12 hours, effects of diuretics. 
 RD +  
vehicle (5) 
RD + 
furosemide (8) 
LNaHK + 
vehicle (12) 
LNaHK + 
furosemide (7) 
Body weight (g) 21.9 ± 0.3 22.0 ± 0.1 22.8 ± 0.3 19.8 ± 0.3# 
Kidney weight (g) 0.27 ± 0.01 0.27 ± 0.01 0.28 ± 0.01 0.27 ± 0.01 
Food intake (g/day) 0.2 ± 0.1 0.7 ± 0.3 0.6 ± 0.1 0.2 ± 0.1# 
Water intake (mL/day) 0.4 ± 0.1 1.3 ± 0.4 2.1 ± 0.3$ 1.9 ± 0.6 
Urine flow (mL/day) 1.3 ± 0.2 2.6 ± 0.5 2.1 ± 0.2 3.4 ± 0.6# 
Urine osmolality (mOsm) 2276 ± 332 1521 ± 308 1878 ± 186 786 ± 123# 
UNaV̇ (µmol/day) 142 ± 63 315 ± 47* 6.2 ± 0.6$ 72.6 ± 15.7# 
UKV̇ (µmol/day) 339 ± 17 390 ± 48 1132 ± 148$ 609 ± 113# 
Hematocrit (%) 41.2 ± 1.2 48.2 ± 1.4* 40.4 ± 1.0 42.4 ± 2.5 
Plasma osmolality 
(mOsm) 
296.7 ± 3.3 295.0 ± 2.7 288.2 ± 4.0 293.3 ± 6.1 
Plasma [Na+] (mM) 155 ± 3 140 ± 3* 151 ± 2 141 ± 1# 
Plasma [K+] (mM) 4.2 ± 0.2 4.1 ± 0.2 6.0 ± 0.3$ 5.8 ± 0.2 
Urine pH 6.4 ± 0.2 5.8 ± 0.1* 6.9 ± 0.1$ 6.0 ± 0.2# 
Parentheses indicate the number of animals. Data are shown as mean ± SEM. *p < 0.05 compared to RD + 
vehicle; #p < 0.05 compared to LNaHK + vehicle; $p < 0.05 compared to RD + vehicle analyzed by two-
way ANOVA with a post-hoc Tukey test. 
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On RD, the mice treated with furosemide exhibited a higher renal K+ clearance than the 
vehicle group. This is expected since furosemide is a K-wasting diuretic by stimulating K+ 
secretion in the distal nephron (137, 138). However, on LNaHK diet, furosemide-treated mice 
had a lower renal K+ clearance than the vehicle group (Figure 8B). To exclude the complicating 
effects of K+ secretion in the distal nephron, mice were treated with furosemide + amiloride and 
amiloride alone, which inhibits the Na+ reabsorbing driving force required for both ROMK- and 
BK-mediated K+ secretion (108, 109). Compared to the amiloride-treated group, the furosemide + 
amiloride group had lower renal K+ clearance on LNaHK diet, but not on RD (Figure 8B). These 
results indicate that the furosemide effect on K+ clearance is independent of the distal K+ 
secretion in mice on LNaHK diet.  
 
To assess the chronic effect of furosemide, WT were kept on LNaHK diet for 7 days and 
then treated them with either furosemide water or control water for 7 days. The results are shown 
in Figure 9 and Table 3. For mice on control water, urinary K+ excretion (UKV̇) was unchanged 
after 7 days. For mice on furosemide water, however, UKV̇ was reduced on the first day of 
furosemide treatment (Figure 9A). After 7 days, plasma [K+] was significantly higher and K+ 
clearance significantly lower in mice on furosemide water compared to control water (Figure 9B, 
C). These results indicate that furosemide is a K-sparing diuretic and can raise plasma [K+] in 
mice on LNaHK diet. 
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Figure 9. Chronic effect of furosemide on renal K+ handling in mice on LNaHK diet.  
A. Urinary K+ excretion (UKV̇) on the day before treatment (day -1), day 1, day 4, and day 7 after treatment 
with control (Ctrl) or furosemide (Furo) water in WT on LNaHK diet. * p < 0.05 compared to LNaHK + 
Ctrl water; # p < 0.05 compared to Day -1 analyzed with two-way repeated measures ANOVA with post-
hoc Holm-Sidak test. B. Plasma [K+] after 7 days of treatment with Ctrl or Furo water in WT on LNaHK 
diet. C. Urinary K+ clearance after 7 days of treatment with Ctrl or Furo water in WT on LNaHK diet. * p < 
0.05 compared to LNaHK + Ctrl water analyzed with one-way ANOVA. 
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Table 3. Metabolic cage measurements for chronic effect of furosemide. 
 LNaHK + Ctrl water (4) LNaHK + Furo water (4) 
Body weight (g) 22.1 ± 0.8 20.9 ± 0.7 
Food intake (g/day) 3.1 ± 0.2 3.4 ± 0.3 
Water intake (mL/day) 8.4 ± 0.8 15.4 ± 1.6* 
Urine flow (mL/day) 4.0 ± 0.2 6.0 ± 0.2* 
Urine osmolality (mOsm) 1872 ± 105 1002 ± 77* 
UNaV̇ (µmol/day) 35.7 ± 7.5 43.6 ± 2.8 
UKV̇ (µmol/day) 3323 ± 283 2620 ± 152 
Hematocrit (%) 41.4 ± 1.2 42.3 ± 1.7 
Plasma osmolality (mOsm) 295 ± 2.6 295 ± 2.6 
Plasma [Na+] (mM) 139.5 ± 1.1 137.1 ± 1.3 
Plasma [K+] (mM) 4.4 ± 0.1 5.3 ± 0.3* 
K Clearance (mL/day) 758 ± 76 498 ± 42* 
Urine pH 9.2 ± 0.1 8.6 ± 0.1* 
Parentheses indicate the number of animals. Data are shown as mean ± SEM. *p < 0.05 compared to 
LNaHK + Ctrl water analyzed by one-way ANOVA. 
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One possible explanation for the effect of furosemide in mice on LNaHK diet is that net 
K+ secretion in the TAL is inhibited. To test this hypothesis more directly, micropuncture 
techniques were used to measure the K+ concentration in the EDT (EDT [K+]) before and after 
intravenous (IV) administration of vehicle or furosemide in mice on RD or LNaHK diet. As 
shown in Figure 10, vehicle administration did not affect the EDT [K+] in mice on either diet. 
Before furosemide treatment, the EDT [K+] was significantly higher in mice on LNaHK diet than 
RD. Furosemide infusion increased the EDT [K+] in mice on RD but decreased EDT [K+] in mice 
on LNaHK diet without affecting MAP or GFR during the collection period (Table 4). These 
results indicate furosemide-sensitive net K+ reabsorption in the TAL of mice on RD and net K+ 
secretion in mice on LNaHK diet. 
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Figure 10. Effect of furosemide on EDT [K+] in mice on RD or LNaHK diet.  
A-D. Representative recordings of K-selective microelectrodes in the lumen of EDT before and after IV 
injections of vehicle or furosemide in WT on RD or LNaHK diet. Arrows indicate the time of injections. E 
and F. EDT [K+] of mice on RD (E) or LNaHK diet (F) before and after IV furosemide injections. N = 4 
per group. *p < 0.05 vs before furosemide analyzed using a paired t-test. 
 
36 
 
 
Table 4. Hemodynamic measurements in micropuncture experiments. 
 WT RD (4) WT LNaHK (5) WT HK (4) ROMK KO LNaHK (4) 
MAP 
(mmHg) 
Before Furo 108.7 ± 6.6 102.7 ± 3.0 100.0 ± 8.6 96.4 ± 8.4 
After Furo 107.7 ± 7.4 103.4 ± 3.6 100.0 ± 10.0 96.0 ± 9.2 
GFR 
(µL/min/g) 
Before Furo 9.3 ± 1.7 9.3 ± 1.1 7.1 ± 0.6 4.8 ± 0.6* 
After Furo 9.4 ± 0.5 8.4 ± 1.1 6.0 ± 1.1 5.5 ± 0.3* 
Numbers in parentheses indicate the number of animals. Data are shown as mean ± SEM. *p < 0.05 
compared to WT LNaHK analyzed by two-way ANOVA with a post-hoc Tukey test. 
  
37 
 
Normal Na, high K+ diet  
  The net K+ secretion in the TAL may be partly due to the high interstitial K+ 
concentration generated by medullary K+ recycling in mice on HK diet (122, 139). We examined 
whether there was net K+ secretion in the TAL of mice on HK diet. As revealed by the results of 
micropuncture experiments in Figure 11, furosemide did not affect the EDT [K+] of WT on HK 
diet despite decreased urine osmolality as an indication of its effectiveness (Figure 11A and B). 
There was no significant difference in MAP and GFR before and after furosemide treatment 
(Table 4). 
These results suggest that the low Na+ content of LNaHK diet is essential for net K+ 
secretion in the TAL. Studies have shown that HK diet can reduce NKCC2 activity, probably by 
inhibiting Cl- exit from the TAL(122). In agreement with this notion, compared to vehicle, the 
furosemide-treated mice exhibited higher UNaV̇ than vehicle group in WT on RD, but not in WT 
on HK diet (Figure 12A). In contrast to WT on HK diet, the furosemide group exhibited higher 
UNaV̇ than vehicle in mice on LNaHK diet (Figure 8A). Because of the difference in dietary Na+ 
content, we were unable to compare the furosemide-sensitive UNaV̇ between mice on RD and 
LNaHK diet using metabolic cage experiments. Thus, the furosemide-sensitive UNaV̇ was 
evaluated during micropuncture experiments, in which all mice received the same IV infusion for 
the same time period. The mice on LNaHK diet exhibited significantly greater furosemide-
sensitive UNaV̇ than those on RD or HK diet. There was no significant difference in furosemide-
sensitive UNaV̇ between mice on RD and HK diet (Figure 12B). 
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Figure 11. Effect of furosemide on EDT [K+] and urine osmolality of mice on HK diet.  
A. EDT [K+] of mice on HK diet before and after IV furosemide injection. B. Urine osmolality of mice on 
HK diet before and after furosemide. N = 4 per group. *p < 0.05 vs before furosemide analyzed using a 
paired t-test. 
  
  
39 
 
 
Figure 12. Effect of furosemide on urinary Na+ excretion in mice on RD or HK diet.  
A. Twelve-hour UNaV̇ of mice on RD or HK diet treated with IP injections of vehicle or furosemide. N = 8 
per group. *p < 0.05 vs vehicle analyzed using two-way ANOVA with a post-hoc Tukey test. B. 
Furosemide sensitive UNaV̇ normalized to body weight of mice on RD, LNaHK diet, or HK diet. N = 4 – 9 
per group. *p < 0.001 vs RD; #p < 0.05 vs LNaHK diet analyzed by one-way ANOVA. 
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Role of ROMK in net K+ secretion 
 Both 30 pS and 70 pS inward rectifying K+ channels (Kir) have been reported to 
represent ROMK in the apical membrane of TAL(37, 140). To investigate which K+ channel 
mediates net K+ secretion, Dr. Huaqing Li in our lab performed single-channel patch clamp 
experiments on split-open TALs from WT and ROMK knockouts (ROMK KO) on RD or 
LNaHK diet. Whereas the 70 pS Kir appeared as one or two channels in a patch, we often found 
the 30 pS Kir as multiple channels (2-5) in a patch. Figure 13A shows recordings of a single 30 
pS Kir (top; -Vp = -60 mV) and multiple 30 pS Kir (middle and bottom; -Vp = -40 mV) in cell-
attached patches from TALs of WT and ROMK KO. No difference was found in Po of the 30 pS 
Kir from mice on LNaHK diet compared with RD (Figure 13C). However, as shown by the 
recordings of Figure 13B and the summary plot of Figure 13C, the Po of the 70 pS Kir (-Vp = -
40 mV) was greater in mice on LNaHK diet compared with RD. 
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Figure 13. Patch clamp recordings of apical K+ channels in the TAL of mice on RD and LNaHK diet 
(performed by Dr. Huaqing Li).  
A. Recordings of single (top; RD, -Vp = -60 mV) and multiple (-Vp = -40 mV) 30 pS (inward currents) K+ 
channels from cell-attached patches of split-open TAL of WT and ROMK KO mice on RD or LNaHK diet. 
Pipette solution contained 140 mM KCl. Red lines denote closed states. B. Recordings of 70 pS Kir 
channels in apical membrane of WT mice. The recordings indicate 2 closed states (long and short) with an 
increased duration in long closed state in channels of mice on RD. C. Summary of Po at –Vp = -40 mV of 
the 30 pS and 70 pS Kir in the TAL from WT on RD and LNaHK diet. *p < 0.05 vs RD analyzed by one-
way ANOVA. 
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Table 5 shows the number and conductance of apical K+ channels in the TALs from WT 
and ROMK KO on RD or LNaHK diet. The single channel conductance of the “30 pS” Kir varied 
with a range of 25 to 38 pS (inward currents) in cell-attached patches and was not significantly 
different among the four groups. Likewise, the single channel conductance of the 70 pS Kir and 
the BK channel was not different in WT on LNaHK diet compared with RD. The same density 
(channels per patch) of 30 pS Kir was found in all four groups. The densities of the 70-pS Kir and 
BK in WT were also not significantly different between the two diets. However, unlike the 30 pS 
Kir, no 70 pS Kir was found in the TAL from ROMK KO on RD nor LNaHK diet. Overall, these 
results show that only the 70 pS Kir is ROMK in the TAL and the 70 pS ROMK channel was 
more active in the apical membranes in mice on LNaHK diet, compared to RD.  
Consistent with the patch clamp results, immunofluorescence staining showed similar 
labeling of ROMK in the apical membrane of TAL for WT on both diets (Figure 14A-F). The 
antibody specificity was validated by ROMK KO as a negative control (Figure 14G-I). 
To further determine the role of ROMK in the TAL net K+ secretion in vivo, 
micropuncture was used to measure the EDT [K+] before and after IV furosemide in ROMK WT 
and ROMK KO on LNaHK diet. As shown in Figure 15A, WT on LNaHK diet exhibited 
furosemide-sensitive net K+ secretion in the TAL. However, as shown in Figure 15B, ROMK KO 
on LNaHK diet did not exhibit furosemide-sensitive net K+ secretion. These results indicate that 
ROMK is required for the net K+ secretion in the TAL of mice on LNaHK diet. 
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Table 5. Number and conductance of apical K+ channels in the TAL. 
 Diet N of mice N of patches 
30 pS Kir 70 pS Kir BK 
P# C# G (pS) P# C# G (pS) P# C# G (pS) 
WT RD 8 17 7 13 31.4 ± 1.4 7 11 70.7 ± 2.2 2 5 165.0 ± 5.0 
WT LNaHK 7 27 4 5 34.7 ± 0.5 5 6 69.8 ± 0.9 4 6 185.2 ± 24.3 
KO RD 5 20 6 12 35.5 ± 0.6 0* 0  1 1 225.8 
KO LNaHK 4 17 6 9 34.2 ± 1.7 0 0  0 0  
Experiment performed by Dr. Huaqing Li. “P#” denotes the number of patches that contain one or more 
respective channel. “C#” denotes the total number of respective channels.  “G” denotes single channel 
conductance (mean ± SEM). *p < 0.05 compared to WT analyzed by a chi-squared test. 
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Figure 14. ROMK localization in the TAL of mice on RD and LNaHK diet.  
A-C. Immunostaining of ROMK (green), Tamm-Horsfall Protein (THP; marker of TAL; red), and both in 
the outer medulla of WT on RD. D-F. Immunostaining of ROMK (green), THP (red), and both in the outer 
medulla of WT on LNaHK diet. G-I. Immunostaining of ROMK (green), THP (red), and both in the outer 
medulla of ROMK KO on RD. All images were taken at 400X magnification. All scale bars are 10 µm. 
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Figure 15. Effect of furosemide on EDT [K+] in ROMK WT and KO on LNaHK diet.  
A and B. EDT [K+] of ROMK WT (A) and KO (B) on LNaHK diet before and after IV furosemide 
injection. N = 7 for WT; N = 3 for ROMK KO. *p < 0.05 vs before furosemide, analyzed by a paired t-test. 
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Discussion 
The TAL reabsorbs about 25% of filtered K+ via the apical NKCC2 and basolateral K-
selective channels. However, much of the K+ transported by the NKCC2 is recycled back to the 
lumen through the apical ROMK in order to maintain a continual supply of K+ for NaCl 
reabsorption (28, 40). In the ex vivo microperfusion experiments with isolated hamster TAL, 
Tsuruoka et. al. (132) found net K+ reabsorption in the medullary TAL but net K+ secretion in the 
cortical TAL. Bailly et. al. (133) also found a net K+ secretion in isolated perfused mouse cortical 
TALs. However, two other groups failed to observe net K+ secretion with isolated perfused TALs 
(141, 142). The discrepancies are probably due to differences in experimental conditions. 
Nonetheless, net K+ secretion in the TAL has never been described in vivo, and its physiological 
conditions and implications remain unclear. The present study demonstrates in vivo net K+ 
secretion in the TAL of mice that are adapted to LNaHK diet, but not to a high K+ diet with 
normal Na. The 70 pS ROMK channel is the likely avenue for K+ secretion in mice on LNaHK 
diet. 
 
Net K+ secretion in TAL with LNaHK diet 
Furosemide is a widely used diuretic for the treatment of hypertension, edema, congestive 
heart failure, hepatic failure, and chronic kidney disease (143, 144). Empiric potassium is a 
recommended supplement for furosemide due to its K-wasting effect (145). Furosemide inhibits 
NKCC2 in the TAL and increases distal Na+ delivery and flow, thus promoting distal K+ secretion 
in the ASDN (138). Consistent with this understanding, in mice on RD, furosemide increased 
renal K+ clearance. In mice on LNaHK diet, however, furosemide showed the opposite effect of 
reducing renal K+ clearance. The fact that furosemide reduced K+ clearance both in the presence 
and absence of amiloride strongly suggests furosemide-sensitive net K+ secretion in the TAL. 
Notably, 12 hours after IP furosemide injection, renal K+ clearance was decreased, but plasma 
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[K+] was unaffected. This may be due to extrarenal K+ handlings including transcellular shift into 
muscle cells and excretion in the colon (146). Chronic treatment with furosemide for 7 days 
decreased K+ clearance and elevated plasma [K+], demonstrating that furosemide changes from a 
K-wasting to a K-sparing diuretic when the mice are kept on LNaHK diet.  
Additionally, in mice on LNaHK diet, elevated aldosterone along with other factors 
upregulate ENaC, ROMK, and BK expressions and activities to promote K+ secretion in the 
ASDN (42, 99, 101, 109). As shown in Table 2, furosemide still increased urine flow and 
decreased urine osmolality but did not increase UNaV̇ after 7 days. This indicates that the 
increased distal Na+ delivery by furosemide is completely reabsorbed by ENaC, provided that 
NCC in the DCT is completely inhibited by the LNaHK diet (108). Along with increased distal 
flow, furosemide should further stimulate K+ secretion through ROMK and BK in the ASDN. 
However, the overall effect of furosemide in mice on LNaHK diet is a decrease in UKV̇, 
suggesting that the inhibition of TAL net K+ secretion must exceed the stimulation of distal K+ 
secretion. 
Our micropuncture studies provided more direct evidence for net K+ secretion. 
Furosemide had strikingly opposite effects on EDT [K+] in mice on RD and LNaHK diet without 
altering MAP or GFR within the periods of measurements. Because of the high interstitial [K+], 
the paracellular pathway could mediate net K+ secretion. However, the EDT [K+], which was 
initially different in the two diets before treatment, reached similar concentrations a few minutes 
after furosemide injections. This result makes the paracellular pathway unlikely because 
furosemide would not block K+ secreted by the paracellular route. Moreover, for paracellular K+ 
secretion, the EDT [K+] after furosemide should still be greater in mice on LNaHK diet than on 
RD.  
In vivo micropuncture of the mouse distal nephron has the limitation of the absence of 
flow measurements before and after systemic injections of furosemide. Intravenous injections of 
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furosemide will diminish the medullary interstitial gradient and change the flow in the EDT. 
However, with the inhibition of NKCC2 by furosemide, we expect that the tubular fluid in EDT is 
similar to the fluid in late proximal tubule. For mice on LNaHK diet, the EDT [K+] before 
furosemide was higher than after furosemide, suggesting that the [K+] in the EDT was greater 
than [K+] in the late proximal tubule. Along with the opposite effect in mice on RD, we provide 
strong evidence for net K+ secretion in the TAL. Additionally, furosemide may inhibit carbonic 
anhydrase (147), causing more K+ following Na+ delivery to the EDT, which would increase the 
EDT [K+]. Therefore, if furosemide inhibits carbonic anhydrase, the actual amount of furosemide-
sensitive K+ secretion in the TAL of LNaHK diet mice would be greater than that observed. 
 
Role of NKCC2 in net K+ secretion 
The diuretic effect of HK diet was thought to be due to inhibition of NKCC2 (42, 122). 
On LNaHK diet, however, NKCC2 activity is enhanced, indicating that the diuretic effect of 
LNaHK diet is not by the same mechanism as in HK diet. In fact, a recent study by Cornelius et. 
al. (99) showed that in mice on LNaHK diet, the BK-αβ4-mediated K+ secretion in the distal 
nephron may contribute to the diuretic effect. 
Another important finding in our study is that the net K+ secretion in TAL seems to be 
unique for mice on LNaHK diet but not HK diet, probably because of upregulated NKCC2 
activity. This is consistent with a previous ex vivo study showing that NKCC2 was inhibited by 
the high interstitial [K+] in mice on HK diet (122). Without an active NKCC2, the NKA cannot 
supply enough intracellular K+ for secretion. This provides further evidence for transcellular K+ 
secretion. The exact mechanism for increased NKCC2 activity in mice on LNaHK diet needs 
investigation.  
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The low Na+ content of LNaHK diet may result in volume depletion leading to the 
activation of the renin-angiotensin-aldosterone system (RAAS) and elevated plasma vasopressin 
(AVP). Both AVP and angiotensin II (Ang II) are regulators of NKCC2. AVP increases NKCC2 
expression via V2 receptor-mediated pathways (148). However, studies showed that plasma and 
urinary AVP levels were either unchanged or decreased in animals fed a low Na+ diet (149-151). 
The effect of LNaHK diet on plasma AVP remains unclear. Another possible candidate is Ang II. 
Studies showed that a low Na+ diet increased NKCC2 phosphorylation and caused a shift from 
the low-affinity NKCC2A to the high-affinity NKCC2B isoform, partly mediated by the actions 
of Ang II on AT1 receptors (130, 152). Ang II level is greatly increased in mice on LNaHK diet, 
but not on HK diet (99, 127, 153). These findings suggest that elevated Ang II may be responsible 
for the upregulated NKCC2 activity in mice on LNaHK diet. 
 
Role of ROMK in net K+ secretion 
Other K+ channels, including BK channels, have been observed by our laboratory and 
others (76) in the TAL. However, ROMK has been identified as the K+ channel involved in 
recycling the K+ that is reabsorbed by NKCC2 (37, 40, 140). ROMK KO exhibit type 2 Bartter’s 
with extreme natriuretic diuresis (40). Consistent with the previous study (140), our patch clamp 
experiments identified the 70 pS K+ channel as ROMK in the apical membrane of TAL. In 
contrast to the study by Lu et. al. (37), we found the same density and Po of a 30 pS K+ channel 
in ROMK KO. It is possible that ROMK KO exhibited no furosemide-sensitive net K+ secretion 
in the TAL because of decreased NKCC2 activity. However, the increased activity of the ROMK 
channel, but not the 30 pS channel, in WT on LNaHK diet indicates that ROMK mediates the 
observed net K+ secretion.  
Unlike ROMK in the ASDN, the mechanism for regulating ROMK in the TAL is not 
well understood. In the ASDN, ROMK activity is upregulated in response to high dietary K+ by 
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increasing channel density rather than Po (154). Aldosterone-dependent signaling pathways, 
including SGK1 and PKA, promote the forward trafficking of ROMK channels to the apical 
membrane of ASDN by phosphorylating ROMK (42, 103, 155). Interestingly, our patch clamp 
experiments showed that TAL from mice on LNaHK diet exhibited increased Po rather than 
channel density of ROMK. The immunofluorescence staining also indicates that LNaHK diet did 
not affect ROMK trafficking. The recent study by Dong et. al. (43) demonstrated that ROMK1 
isoform, which is expressed in the CCD, but not TAL, was required for ROMK trafficking in 
response to high K+ intake. This study suggests that the ROMK2 isoform in the TAL is regulated 
by different signaling pathways than the ROMK1 in the ASDN. Mice on LNaHK diet have highly 
elevated aldosterone and Ang II compared to RD (99, 127, 153). Since the TAL is absent of 11-β-
hydroxysteroid dehydrogenase 2 (156), aldosterone is unlikely to regulate ROMK in TAL. 
WNK1, WNK3, and WNK4 all regulate ROMK by affecting clathrin-dependent endocytosis in 
the ASDN (97). Thus, the WNKs are unlikely to regulate the Po of ROMK in the TAL. The patch 
clamp study by Lu et. al. (157) also showed that Ang II regulates the activity of the 70 pS ROMK 
in the TAL. Thus, Ang II may play a role to increase ROMK activity in the TAL of mice on 
LNaHK diet.  
Intracellular pH is another important regulator of ROMK activity. Like other Kir 
channels, the Po of ROMK is highly sensitive to intracellular pH (30). The urine pH was higher 
in mice on LNaHK diet than on RD due to the alkaline dietary content. However, the dietary 
effect on the intracellular pH of TAL cells remains unclear. 
 In summary, we have provided in vivo evidence of furosemide-sensitive net K+ secretion 
in the TAL of mice on LNaHK diet. Net K+ secretion is dependent on increased NKCC2 activity 
and may be mediated by ROMK. With net K+ secretion in the TAL, furosemide becomes a K-
sparing diuretic and may lead to hyperkalemia. As summarized in Figure 16, furosemide inhibits 
the net K+ reabsorption in the TAL of mice on RD, increasing distal Na+ delivery and flow, 
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thereby promoting K+ secretion through ROMK and BK channels in ASDN. In mice on LNaHK 
diet, upregulated ROMK and NKCC2 activity results in net K+ secretion in the TAL via ROMK 
channels. Elevated plasma aldosterone on LNaHK diet upregulates ENaC, ROMK, and BK in 
ASDN to promote distal K+ secretion. Furosemide not only inhibits the net K+ secretion in the 
TAL but also increases distal flow and Na+ delivery that further stimulate distal K+ secretion. The 
net result of these two opposing effects is a decrease in K+ excretion. Our finding is especially 
important when considering diuretic treatments for patients consuming a healthy low Na+ high K+ 
diet, which changes furosemide from a K-wasting to a K-sparing diuretic.  
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Figure 16. Summary figure of dietary effects on furosemide actions on urinary K+ excretion.  
A. On RD diet, furosemide blocks NKCC2, inhibiting net K+ reabsorption in the TAL while increasing 
distal Na+ delivery and flow, which stimulates K+ secretion through ROMK and BK in ASDN. The net 
effect of furosemide is an increase in urinary K+ excretion. B. On LNaHK diet, up-regulated NKCC2 and 
ROMK, possibly by Ang II, results in net K+ secretion in the TAL. Elevated aldosterone (Aldo) from 
LNaHK diet upregulates ENaC, ROMK, and BK in the ASDN to promote distal K+ secretion. Furosemide 
blocks NKCC2, inhibiting net K+ secretion in the TAL. Although furosemide increases distal Na+ delivery 
and flow that stimulate K+ secretion in ASDN, the net result is a decrease in urinary K+ excretion. 
Transporters in the basolateral membrane and cell types of ASDN have been omitted for simplicity. 
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CHAPTER 2: FUROSEMIDE REDUCES BKαβ4-MEDIATED K+ 
SECRETION IN MICE ON A NORMAL NA HIGH K+ DIET 
Introduction 
 K+ is freely filtered into the glomerulus, reabsorbed in the proximal tubule and TAL, and 
secreted into the lumen in the distal nephron via ROMK and BK channels. ROMK channels are 
considered constitutively active and secrete K+ at the basal conditions (22, 23). By contrast, BK 
channels are activated by high urinary flow and secrete K+ under high dietary K+ conditions (24, 
25). In particular, the BK-αβ4 channel located in the intercalated cells of distal nephron (85) is 
required to maintain K+ homeostasis in mice on an alkaline high K+ diet (127). The BK-β4 
subunit of the BK-αβ4 channel is an accessory subunit that protects the pore-forming BK-α 
subunit from lysosomal degradation (58). BK-β4 is regulated by the acidity/alkalinity of the diet 
(90). Compared to those on a high KCl diet (HKCl), mice on an alkaline HK diet exhibited 
increased BK-β4 expression and increased apical membrane localization of BK-α (90). However, 
it is unclear whether BK-β4 is regulated by tubular fluid pH or plasma pH. 
 Diuretics are among the most commonly used medications in the US. More than 20% of 
the population over the age of 65 are taking diuretics in the US (106). Numerous studies have 
shown the influences of high dietary K+ intake on the actions and effectiveness of diuretics. 
Compared to those on a regular diet, mice on HK diet exhibit diminished thiazide-sensitive 
natriuresis due to decreased NCC activity (105, 158) but enhanced amiloride-sensitive natriuresis 
due to upregulated ENaC activity (108, 109). Furosemide has a reduced natriuretic effects on HK 
diet (122, 159), but increased efficacy on LNaHK diets (159).  
Additionally, furosemide is well known for its effect to acidify the urine. Classically, this 
was thought to be due to increased Na+ delivery to distal nephron, generating a more favorable 
negative lumen potential for H+ secretion from the vacuolar H+-ATPase (V-ATPase) (160, 161). 
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Chronic furosemide treatment increases V-ATPase expression (162). More recently, the study by 
de Bruijn et. al. (163) showed that furosemide acidifies the urine by increasing H+ secretion via 
the Na+-H+ exchanger 3 (NHE3) in the TAL. Taking these together with the notion that BK-β4 is 
regulated by pH, we hypothesize that in mice on HK diet, furosemide reduces BK-αβ4-mediated 
K+ secretion by acidifying the urine.  
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Methods 
Animals 
 All animals were maintained in accordance with the Institutional Animal Care and Use 
Committee of the University of Nebraska Medical Center. Wild-type mice with C57BL/6 
background (Charles River Laboratories, Wilmington, MA) and BK-β4 knockout mice with 
C57BL/6 background (generously provided by R. Brenner, Stanford University, CA) were housed 
in the UNMC animal facility and maintained on a 12-hour day-night cycle, with free access to 
water and food.  
Metabolic cage 
Wild-type (WT) and BK-β4 knockout mice (β4-KO), both male and female, at 12–16 
weeks of age, were kept on either a regular diet (RD; 0.3% Na, 0.6% K), an alkaline high K+ diet 
(HK diet; 5.0% K+ with 5% of equal carbonate/citrate/Cl and 0.32% Na+; TD.07278; Envigo, 
Indianapolis, IN), and regular drinking water for 7 days. They were then given either control 
water (0.8 mM KHCO3 in drinking water) or furosemide water (0.1 g/L furosemide + 0.8 mM 
KOH for HK diet; 0.4 g/L furosemide + 0.8 mM KOH for RD) for 11 days. Another group of WT 
mice were kept on HK diet for 7 days and then given furosemide + acetazolamide water (0.1 g/L 
furosemide + 0.4 g/L acetazolamide + 2.0 mM KOH) for 7 days. All mice were acclimated to 
metabolic cages for one day each time, for a total of three times before experiments. Urine was 
collected for 24 hours in metabolic cages on the day before treatment water and 1, 4, 7, and 11 
days after treatment. The mice were then anesthetized, sacrificed by exsanguination from the 
carotid artery, and blood and kidneys were collected. Urine pH was measured with a pH meter 
(Model 215, Denver Instruments, Bohemia, NY). Arterial blood gas values and hematocrit were 
determined by the MN 300 i-STAT system with EC8+ cartridges (Abbott Point of Care, 
Princeton, NJ). Urine and plasma osmolality were measured with an osmometer (Model 3250, 
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Advanced Instruments, Norwood, MA). Urine and plasma Na+ and K+ concentrations were 
determined by a flame photometer (PFP7, Jenway, Burlington, NJ). 
Perfusion-fixation and immunofluorescence staining 
 Kidneys were fixed with 2% paraformaldehyde as previously described (164). Mice were 
anesthetized with ketamine/xylazine cocktail, and chest cavity was opened. PBS containing 2% 
paraformaldehyde was perfused via the left ventricle for 5 minutes. The kidneys were then 
removed and cut into slices, which were fixed in 2% paraformaldehyde at 4 °C overnight. 
Specimen were then embedded in paraffin and cut into serial sections on slides. Procedures for 
immunofluorescence staining were previously described (89). The following primary antibodies 
were used: anti-BK-α (mouse, diluted 1:100, UC Davis/NIH NeuroMab, Davis, CA), anti-V-
ATPase B1 (rabbit, diluted 1:100, Santa Cruz), and anti-calbindin-D28K (mouse, diluted 1:100, 
Sigma, St. Louis, MO). The following secondary antibodies were applied for 1 hour at room 
temperature: donkey anti-mouse IgG conjugated Alexa Fluor 488 and donkey anti-rabbit IgG 
conjugated Alexa Fluor 594 (diluted 1:200, Invitrogen, Carlsbad, CA). The stained sections were 
mounted using EMS Shield Mount with DABCO (Electron Microscopy Sciences, Hatfield, PA). 
Western blotting 
Kidneys were collected from sacrificed mice, and kidney cortex was separated from 
medulla tissue and used for Western blotting as previously described (99, 134). Kidney samples 
were placed in cold lysis buffer containing RIPA buffer + protease/phosphatase inhibitor (Sigma, 
St Louis, MO) + 0.1% Triton X-100 (Sigma, St Louis, MO) + 1mM PMSF (Sigma, St Louis, 
MO). Samples were cut into small pieces, sonicated, and kept on ice for 30 min before 
centrifuged at 12500 g for 30 min at 4 °C. Supernatant was collected, to which 4X Laemmli 
sample buffer (Bio-Rad, Hercules, CA) containing 10% β-mercaptoethanol (Sigma, St Louis, 
MO) was added. Samples were boiled for 5 min and loaded into 4 – 20% gradient gel (Bio-Rad) 
and run at 100 V for 1.5 hrs. The gel was then transferred onto Amersham Hybond-P membrane 
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(GE Healthcare Life Sciences, Pittsburgh, PA) at 100 V for 1 hr. The membrane was then 
blocked with 3% BSA 3% non-fat milk in TBS-T for 1 hr at room temperature. It was then 
incubated with primary antibodies in blocking buffer overnight at 4 °C. The next day, the blot 
was washed in TBS-T for 5 min 3 times and incubated with secondary antibodies for 1 hr at room 
temperature. The blot was then washed and developed with Femto reagent (Thermo Fisher 
Scientific) and imaged. Primary antibodies included anti-BK-β4 (rabbit polyclonal, diluted 1:500, 
Alomone Laboratories, Jerusalem, Israel), anti-NHE3 (mouse monoclonal, diluted 1:200, 
Invitrogen, Carlsbad, CA), and anti-V-ATPase B1 (rabbit polyclonal, diluted 1:200, GeneTex, 
Irvine, CA). Secondary antibodies included goat anti-mouse IgG HRP-conjugated (diluted 
1:15,000, Santa Cruz Biotechnology, Santa Cruz, CA), goat anti-rabbit IgG HRP-conjugated 
(diluted 1:15,000, Santa Cruz Biotechnology, Santa Cruz, CA), and anti-β-actin HRP-conjugated 
(diluted 1:15,000, Thermo Fisher Scientific, Waltham, MA). Densitometry analysis was 
performed using imageJ software. 
Aldosterone Measurement 
Plasma aldosterone levels were measured using the aldosterone ELISA kit EIA-5298 
(DRG Diagnostics, Marburg, Germany) following manufacturer’s protocol.  
HPLC measurement of furosemide concentration 
 The concentrations of furosemide in urine were determined with high-performance liquid 
chromatography (HPLC) as previously described (165). The instrument (Agilent LC 1200; Santa 
Clara, CA) was connected to a G1321A Agilent fluorescent detector and the chromatograms were 
recorded using Agilent ChemStation software. A C18 column (Waters Spherisorb 10.0 µm) was 
used as the stationary phase. The mobile phase consisted of cetonitrile – 0.125 M SDS – 0.01 M 
perchloric acid (234.6:35:665, w/w) pumped at a constant flow-rate of 0.6 ml/min. The retention 
time of furosemide was 3.7 min and was separated from the rest of the compounds present in 
urine and plasma in chromatographs obtained with excitation at 360 nm and emission at 413 nm. 
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A standard curve was constructed using the areas under the furosemide peak of plasma samples 
containing 0, 10, 20, 50, 100, 200, 500, 1000, 2000, and 5000 µM furosemide. The furosemide 
concentrations of urine samples were then calculated using the standard curve. 
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Results 
Furosemide effect on urine pH 
Consistent with the urine acidification effect of furosemide (138, 163, 166, 167), our 
results showed that over the course of treatment, furosemide water (Furo) reduced urine pH in 
both WT and β4-KO on HK diet (Figure 17). However, blood pH was not different between the 
HK + Ctrl and HK + Furo group (Table 6). Notably, urine pH kept decreasing until day 7. This 
gradual reduction could be due to increased V-ATPase expression in the distal nephron (162). 
Indeed, compared to HK + Ctrl group, the HK + Furo group had higher V-ATPase expression 
(Figure 18A). The NHE3 expression remained unchanged in the whole kidney and the medulla 
(Figure 18). Since V-ATPase expression is regulated by aldosterone, we measured the plasma 
aldosterone levels. HK + Furo group had significantly higher plasma aldosterone levels compared 
to HK + Ctrl group (Table 6). 
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Table 6. Blood measurements after 11 days (or 7 days for HK + Furo Actz) of treatment 
Genotype WT KO 
Treatment HK + Ctrl HK + Furo HK + Furo Actz RD + Ctrl RD + Furo HK + Ctrl HK + Furo 
Number of Mice 12 14 3 4 4 8 7 
Plasma Na+ (mM) 137.6 ± 1.1 140.9 ± 1.0* 143.5 ± 8.2 138.3 ± 0.7 138.0 ± 1.3 139.8 ± 1.2 140.1 ± 1.0 
Hct (%) 36.5 ± 0.3 39.8 ± 0.5* 38.3 ± 1.5 37.0 ± 0.6 40.5 ± 0.6* 35.4 ± 0.3 38.0 ± 1.2* 
Blood pH 7.46 ± 0.02 7.45 ± 0.03 7.44 ± 0.03 7.46 ± 0.02 7.46 ± 0.03  7.45 ± 0.03 
P Aldo (pg/mL) 862 ± 165 1489 ± 179*           
  
*p < 0.05 vs Ctrl group; #p < 0.05 vs Furo group analyzed with two-way ANOVA with a post-
hoc Tukey test. 
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Figure 17. Furosemide effect on urine pH.  
Urine pH of WT (A) and β4-KO (B) on day -1, 1, 4, 7, and 11 of Ctrl and Furo treatments, or day -1, 1, 4, 
and 7 of Furo + Actz treatment. *p < 0.05 vs. HK + Ctrl water; #p < 0.05 vs. Day -1, analyzed with two-
way repeated measures ANOVA with a post-hoc Holm-Sidak test (p < 0.001 for both treatment and days 
with interaction p < 0.01). N = 4 – 14 animals per group. 
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Figure 18. Western blot and quantification of NHE3 and V-ATPase expressions normalized to β-
actin in mice treated with HK + ctrl and HK + furo.  
*p < 0.05 vs. HK + Ctrl analyzed with a student’s t-test. N = 4 animals per group. 
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Furosemide effect on renal K+ handling  
As a well-known K-wasting diuretic, in mice on RD, Furo water group had a significantly 
lower plasma [K+] and a higher trend of K+ clearance compared to the Ctrl water group (Figure 
19). However, in WT on HK, Furo treatment reduced UKV̇ on day 1 (Figure 20). After 11 days of 
treatment, the HK + Furo group had a lower K+ clearance and higher plasma [K+] than the HK + 
Ctrl group (Figure 21). This indicates that furosemide becomes a K-sparing diuretic in mice on 
HK. Interestingly, this effect seems to be dependent on BK-β4 since furosemide did not affect K+ 
clearance or plasma [K+] in β4-KO on HK (Figure 21).  
To test whether the furosemide effect on K+ excretion is due to urine acidification, 
another group of mice on HK were treated with furosemide water with acetazolamide added to 
alkalinize the urine (HK + Furo Actz). Because of volume depletion in HK + Furo Actz mice, the 
treatment was 7 days instead of 11 days. The addition of Actz successfully kept the urine alkaline 
without affecting the blood pH (Figure 17, Table 7). Unlike HK + Furo, HK + Furo Actz group 
showed similar UKV̇, plasma [K+], and renal K+ clearance as HK + Ctrl group (Figure 20, Figure 
21). Interestingly, the combination of furosemide and acetazolamide produced a much more 
profound diuresis than furosemide alone (Table 7), consistent with the recognized synergistic 
effect of these two diuretics (168, 169). 
Tubular fluid pH is well known to be positively correlated with K+ secretion in the distal 
nephron (170, 171). To illustrate this relationship, we plotted renal K+ clearance vs urine pH and 
included data from WT and β4-KO kept on HKCl diet. Consistent with this notion, in WT on HK, 
renal K+ clearance was positively correlated with urine pH. However, such a correlation was not 
significant for β4-KO on HK (Figure 22). This indicates that the correlation between urine pH 
and K+ clearance was dependent on BK-β4 expression. 
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Figure 19. Furosemide effect on plasma [K+] and renal K+ clearance in mice on RD.  
Plasma [K+] (A) and renal K+ clearance (B) of WT on RD on day 11 of Ctrl or Furo treatments. *p < 0.05 
vs. RD + Ctrl analyzed with a student’s t-test. N = 4 animals per group.  
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Figure 20. Furosemide effect on urinary K+ excretion (UKV̇) in mice on HK.  
UKV̇ of WT (A) and β4-KO (B) on day -1, 1, 4, 7, and 11 of Ctrl and Furo treatment, or day -1, 1, 4, and 7 
of Furo + Actz treatment. *p < 0.05 vs. HK + Ctrl, #p < 0.05 vs. Day -1, analyzed with two-way repeated 
measures ANOVA (p < 0.05 for drug treatment in WT) with a post-hoc Holm-Sidak test. N = 4 – 17 per 
group. 
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Figure 21. Furosemide effect on plasma [K+] and renal K+ clearance in mice on HK.  
Plasma [K+] (A) and renal K+ clearance (B) of WT and β4-KO on day 11 of Ctrl and Furo treatment, or day 
7 of Furo + Actz treatment. *p < 0.05 vs. HK + Ctrl; #p < 0.05 vs. HK + Furo, analyzed with two-way 
ANOVA with a post-hoc Tukey test (p < 0.001 for treatment in plasma [K+]; p < 0.01 for treatment in renal 
K+ clearance). N = 4 – 17 animals per group. 
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Table 7. Metabolic cage measurements after 11 days (or 7 days for HK + Furo Actz) of treatment 
Genotype WT KO 
Treatment HK + Ctrl HK + Furo HK + Furo Actz RD + Ctrl RD + Furo HK + Ctrl HK + Furo 
Number of Mice 12 14 6 4 6 8 7 
Body Weight (g) 22.4 ± 0.4 21.4 ± 0.5 20.5 ± 0.8 18.9 ± 1.4 19.2 ± 2.1 21.0 ± 0.6 19.1 ± 0.7 
Food Intake (g/day) 2.55 ± 0.18 2.20 ± 0.13 2.00 ± 0.62 0.09 ± 0.04 0.21 ± 0.07 2.65 ± 0.23 2.23 ± 0.48 
Water Intake 
(mL/day) 
14.8 ± 1.1 12.7 ± 1.1 16.0 ± 2.2 1.1 ± 0.4 5.5 ± 1.6* 10.5 ± 1.1 12.8 ± 1.0 
V̇ (mL/day) 7.2  ± 0.7 7.1 ± 0.6 10.3 ± 1.5# 0.7 ± 0.2 2.6 ± 0.8 5.4 ± 0.6 6.8 ± 0.7 
U Osm (mOsm) 1020 ± 73 809 ± 47* 720 ± 39* 2725 ± 452 1367 ± 451* 1173 ± 42 908 ± 81* 
UNaV̇ (µmol/day) 277 ± 18 281 ± 11 336 ± 47 142 ± 19 129 ± 26 284 ± 25 302 ± 45 
 
*p < 0.05 vs Ctrl group; #p < 0.05 vs Furo group analyzed with two-way ANOVA with a post-
hoc Tukey test. 
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Figure 22. Correlation between renal K+ clearance and urine pH in WT (A) and β4-KO (B) on HK.  
Solid circles denote HK + Ctrl group; empty circles denote HK + Furo group; solid triangles denote HK + 
Furo Actz group; empty triangles denote HKCl group. 
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Furosemide effect on BK-αβ4 expression 
Previous studies showed that the alkalinity/acidity of diets regulates the BK-αβ4-
mediated K+ secretion by altering BK-β4 expression, which is required for maintaining the apical 
localization of BK-α(58, 90). We hypothesized that furosemide would have similar effects by 
acidifying the urine. Shown by the western blot in Figure 23 and the immunofluorescent staining 
in Figure 24, compared to HK + Ctrl group, HK + Furo group but not HK + Furo Actz group had 
significantly reduced BK-β4 expression and decreased apical localization of BK-α in the kidney 
cortex. Interestingly, in HK + Ctrl group, BK-α was only located in the apical membrane of 
intercalated cells of CNT but not CCD or MCD, as evidenced by co-staining with V-ATPase (IC 
marker) and calbindin (DCT/CNT marker). Consistent with this differential regulation of BK-α in 
different nephron segments, the BK-β4 expression in the whole kidney remained unaffected by 
Furo treatment (Figure 23C). 
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Figure 23. Furosemide effect on BK-β4 expression in the kidney.  
BK-β4 expression normalized to β-actin in the whole kidney (A) and kidney cortex (B) of WT on HK 
treated with Ctrl vs Furo water. C. BK-β4 expression normalized to β-actin in the kidney cortex of WT on 
HK treated with Ctrl vs Furo Actz water *p < 0.05 vs. HK + Ctrl analyzed with a student’s t-test. 
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Figure 24. BK-α localization in kidney sections of WT on HK treated with Ctrl or Furo water.  
A-D: Representative images from the CNT of HK + Ctrl group. E-H: Representative images from the CNT 
of HK + Furo group. I-L: Representative images from the CNT of HK + Furo Actz group. M-P: 
Representative images from the CCD of HK + Ctrl group. Q-S: Representative images from the MCD of 
HK + Ctrl group. A, E, I, M, Q were stained with anti-BK-α; B, F, J, N, R were stained with anti-V-
ATPase; D, H, L, P were serial sections of their respective row and stained with anti-Calbidin-D28K. Scale 
bars are 10 µm.  
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Discussion 
 The results of the present study demonstrate the following: 1) chronic furosemide 
treatment acidified the urine partly by upregulating V-ATPase expression; 2) chronic furosemide 
treatment reduced renal K+ clearance and increased plasma [K+] in WT but not BK-β4 KO on 
HK; 3) chronic furosemide treatment downregulated BK-β4 expression in the cortex and 
decreased BK-α apical localization in the CNT of WT on HK; 4) the effect of furosemide on K+ 
handling and BK-αβ4 was prevented by alkalinizing the urine with acetazolamide.  
 
Urine Acidification by Furosemide 
 Furosemide causes marked urine acidification and is used to diagnose distal renal tubular 
acidosis (166, 172, 173). The classical explanation was similar to the K-wasting effect of 
furosemide. The increased distal Na+ delivery to ENaC generates a more negative lumen potential 
in the ASDN for both K+ and H+ secretion (160). The study by Kovacikova J et. al. (161) also 
showed that the acute urine acidification effect was dependent on ENaC in the CNT. However, 
the recent study by de Bruijin et. al. (163) showed that acutely, furosemide-induced urine 
acidification was caused by increased H+ secretion from NHE3 in the TAL. Another study 
showed that chronic furosemide treatment in mice on a regular diet acidified urine in an ENaC-
independent manner and increased V-ATPase expression without changes in plasma aldosterone 
(162).  
Consistent with previous studies, our data showed that chronically, furosemide reduced 
the urine pH starting from the 1st day of treatment and caused a gradual decrease until day 7. 
After 11 days of treatment, the V-ATPase expression in the whole kidney was doubled. However, 
unlike the previous study (162), our data showed increased plasma aldosterone levels in the HK + 
Furo group, which is consistent with their elevated plasma [K+]. Furthermore, by inhibiting Na+ 
reabsorption in TAL, furosemide inhibits Ca2+ reabsorption in the TAL and sends more Na+ to be 
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reabsorbed by NCC and ENaC, which reduces the driving force for Na+-Ca2+ exchange by Na+-
Ca2+ exchanger 1 (NCX1), inhibiting Ca2+ reabsorption in DCT and CNT (174, 175). In addition 
to aldosterone, the activity of V-ATPase may be stimulated by the increased urinary [Ca2+] via 
the action of Ca-sensing receptor (CaSR) (176). Although the NHE3 expression remained 
unchanged by furosemide, the synergistic effect of furosemide + acetazolamide suggests that 
NHE3 activity may be upregulated during furosemide treatment and contribute to the urine 
acidification by furosemide. Further investigations are required to determine the activity of NHE3 
in the TAL during chronic furosemide treatment. 
 
Furosemide, Urine pH and BK-αβ4-mediated K+ Secretion 
 The link between pH and BK-αβ4 has been previously demonstrated by our lab. As the 
diet becomes more acidic, BK-β4 expression is decreased, reducing apical membrane localization 
of BK-α (58, 90, 99). In the current study, chronic furosemide treatment reduced urine pH, BK-β4 
expression, and apical membrane localization of BK-α in WT on HK. This effect astoundingly 
overrides the K-wasting effect from increased distal Na+ delivery, resulting in an overall decrease 
in renal K+ clearance and an elevation of plasma [K+]. In fact, furosemide did not cause a 
significant increase in urine flow (V̇) or UNaV̇ in mice on HK, despite the fact that the urinary 
concentration of furosemide measured with HPLC was 683 ± 97 µM, about 50 folds higher than 
its IC50 (7.2 – 15.1 µM) (177) (Table 8, Figure 25). This could be because NKCC2 activity is 
partly inhibited in mice on HK (122, 159). However, the effectiveness of furosemide was still 
demonstrated by the further decreased urine osmolality, increased hematocrit, increased plasma 
aldosterone levels, and reduced urine pH in HK + Furo group. Moreover, the less profound 
diuretic and natriuretic effect of furosemide under HK conditions did not stimulate ROMK and 
BK-αβ1-mediated K+ secretion as much as regular dietary conditions. This might have caused the 
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reduction in BK-αβ4-mediated K+ secretion to be the predominant effect and resulted in a net 
decrease in K+ excretion.   
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Table 8. Furosemide concentrations in urine and plasma of WT and BK-β4 KO. 
  WT HK + Furo BK-β4 KO HK + Furo 
[Furo] in urine (µM) 683 ± 97 610 ± 123 
[Furo] in plasma (µM) 6.5 ± 3.2 21.7 ± 17.4 
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Figure 25. A sample HPLC trace for a urine sample.  
It shows a distinct peak at 3.680 min, corresponding to the elution of furosemide. 
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Interestingly, in BK-β4 KO on HK, furosemide acidified the urine without affecting renal 
K+ clearance or plasma [K+], which were comparable to those of WT HK + furo group. These 
results suggest that the K-sparing effect of furosemide in WT on HK is due to the inhibition of K+ 
secretion via BK-αβ4 channels. The K-sparing effect was abolished when the urine is alkalinized 
with acetazolamide. This could also be due to the further increase in distal Na+ delivery 
stimulating K+ secretion. However, the fact that BK-β4 expression and BK-α localization were 
similar between HK + Furo and HK + Furo Actz groups indicates that the furosemide effect on 
BK-αβ4 was due to urine acidification. This synergistic effect was previously reported (169, 178) 
and suggested as a potential combination therapy for the treatment of congestive heart failure 
refractory to high doses of loop diuretics (168). Such patients have increased Na+ reabsorption in 
the proximal tubules, rendering loop diuretics ineffective (179).  
 The apical localization of BK-α is regulated by BK-β4 via its protection from lysosomal 
degradation (58). However, the mechanism of how luminal pH regulates BK-β4 expression 
remains unclear. The pH needs to be sensed from the luminal side of intercalated cells. One 
possible pH sensor is the CaSR located in the apical membrane of both principal cells and 
intercalated cells of the DCT and CD (180). Studies showed that extracellular alkalinization 
above pH 6 increased CaSR activity due to a sensitization towards extracellular Ca2+ (181, 182). 
The activation of CaSR would release Ca2+ from intracellular storage and increase Ca2+ entry via 
TRPV5 channels (183) to further activate BK channels (44). The TRPV4 channel plays a critical 
role in upregulating BK-mediated K+ secretion during adaptation to HK diets (98). The coupling 
of CaSR and TRPV4 was recently demonstrated in gastric cancer cells (184); however, such a 
relationship remains to be investigated in the kidney.  
 Another interesting finding in this study is that pH regulation of BK-αβ4 only occurs in 
the CNT but not CCD or MCD. This was supported by both IF staining, where BK-α was 
localized in the apical membrane of CNT only, and the western blot, where BK-β4 expression 
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was only reduced in the kidney cortex. CNT has been identified as the major site of K+ secretion 
180 and furosemide-induced H+ secretion (161, 185). According to our IF staining, in the CNT, 
BK-α was almost exclusively expressed in the intercalated cells. This agrees with the notion that 
intercalated cells play the major role in BK-mediated flow-induced K+ secretion (83, 97).  
The association between luminal pH and K+ secretion has been known for decades (170, 
171, 186).  Luminal acidification from pH 7.4 to 6.8 impairs K+ secretion in rabbit CCD without 
changing Na+ reabsorption (187). Although ROMK channels are regulated by cytosolic pH (171, 
188), they are insensitive to extracellular pH (41, 188). The intracellular pH of principal cells is 
unlikely to be affected by luminal pH due to lack of acid-base transporter in the apical membrane 
(189). The link between luminal pH and K+ secretion has been attributed to several possibilities 
including a pH-sensitive apical K-Cl cotransporter in principal cells (186), a TASK2 K+ channel 
that is regulated by extracellular pH (186), and ENaC modulation by luminal HCO3- (190). Our 
current study provides another explanation that luminal pH regulates BK-αβ4-mediated K+ 
secretion, as evidenced by our finding that BK-β4 is required for the positive correlation between 
urine pH and renal K+ clearance. 
 
Limitations and conclusions 
 One limitation of our study is the use of drinking water for drug treatment. This method 
is non-invasive and minimizes stress but also makes drug dosage different in each animal. 
According to Table 7, although the water intake is not statistically different among the different 
groups on HK, it may vary among individuals, leading to larger standard errors. Another 
limitation of our study is that at high doses, furosemide may inhibit NCC in the DCT. However, 
NCC activity is highly inhibited on HK due to elevated plasma [K+]. Since the plasma [K+] was 
even higher in HK + Furo group, NCC activity should also be inhibited. Another explanation for 
the K-sparing effect of furosemide is that it may inhibit NKCC1 in the basolateral membrane of 
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intercalated cells to limit K+ secretion through BK (191). However, the plasma concentration of 
furosemide in the HK + Furo group (6.5 ± 3.2 µM) was much lower than its IC50 (23 ± 12 µM) 
(192) (Table 8). Additionally, the restoration of BK-β4 expression and BK-α localization by co-
administration of acetazolamide strongly suggests that furosemide exerts its effect on BK-αβ4 via 
urinary acidification.  
Furosemide is a commonly used K-wasting diuretic, and patients taking furosemide often 
require K+ supplements to prevent hypokalemia. However, our current study found that 
furosemide became a K-sparing diuretic in mice adapted to HK. Instead of the risk for 
hypokalemia, furosemide increased the plasma [K+] in these mice. As shown by our proposed 
model in Figure 26, on a regular diet, ROMK is the main K+ channel responsible for K+ secretion 
in the ASDN. Furosemide increases Na+ delivery to the ASDN, generating a more negative lumen 
potential, increasing K+ secretion via ROMK channels. The increased flow will also activate the 
BK-αβ1 channels in principal cells. The net result is an increase in urinary K+ excretion. On an 
alkaline high K+ diet, furosemide acidifies the urine by increasing H+ secretion from NHE3 and 
V-ATPase. Lower pH downregulates BK-β4 expression, decreasing apical localization of BK-α, 
reducing BK-αβ4-mediated K+ secretion. Because of the less profound natriuretic and diuretic 
effect of furosemide under HK, the increase in ROMK and BK-αβ1-mediated K+ secretion is less 
than the decrease in BK-αβ4-mediated K+ secretion. The net result is a decrease in total K+ 
excretion. 
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Figure 26. Differential effects of furosemide on K+ clearance in mice on regular diet vs an alkaline 
high K+ diet.  
A. On a regular diet, BK-α stays in the cytoplasm, and K+ is mainly secreted via the ROMK channel. 
Furosemide blocks Na+ reabsorption by NKCC2, increasing Na+ delivery to distal nephron, increasing K+ 
secretion via ROMK, leading to increased K+ clearance. B. On an alkaline high K+ diet, K+ is secreted by 
both ROMK and BK channels. Furosemide blocks Na+ reabsorption by NKCC2, increasing Na+ delivery 
and flow to distal nephron, increasing K+ secretion via ROMK and BK-αβ1. On the other hand, furosemide 
increases acid secretion from NHE3 and V-ATPase, acidifying the urine, which decreases BK-β4 
expression and reduces apical localization of BK-α. The net result is a decrease in K+ clearance, making 
furosemide a K-sparing diuretic. 
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In one rat study by Rodicio JL and Hernando L, furosemide and acetazolamide each 
caused increased K+ excretion separately; however, when furosemide was added during 
acetazolamide administration, K+ excretion was reduced despite profoundly increased Na+ 
excretion (178). This phenomenon can be potentially explained by our findings that urine pH 
regulates BK-αβ4-mediated K+ secretion. During acetazolamide administration, urine was 
alkalinized, increasing BK-αβ4-mediated K+ secretion, contributing to the kaliuretic effect of 
acetazolamide. When furosemide was added, urine was acidified, reducing BK-αβ4-mediated K+ 
secretion, leading to decreased kaliuresis despite increased natriuresis. Furthermore, in a clinical 
study, when furosemide and thiazide were administered in doses with equal natriuretic effects, the 
kaliuresis induced by furosemide was lower than that of hydrochlorothiazide (193). This 
phenomenon has been explained by the fact that during furosemide treatment, the Na+ not 
reabsorbed by TAL was picked up by NCC in early DCT, reducing the delivery of Na+ to distal 
K+ secretion sites (193, 194). However, our study provides an alternative explanation that 
furosemide may inhibit BK-mediated K+ secretion, leading to a lower kaliuretic effect than 
thiazide.  
In conclusion, our study indicates that furosemide decreases BK-αβ4-mediated K+ 
secretion by acidifying the urine, making furosemide a K-sparing diuretic in mice adapted to an 
alkaline high K+ diet.  
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GENERAL DISCUSSION 
Major findings of the dissertation 
 In summary, the major findings of this dissertation are: 
1. There is a ROMK-mediated net K+ secretion in the TAL of mice adapted to LNaHK but 
not HK (Chapter 1). 
2. Furosemide decreases renal K+ clearance in mice on LNaHK by inhibiting the net K+ 
secretion in the TAL (Chapter 1). 
3. BK-αβ4 channels are regulated by luminal pH in the intercalated cells of CNT (Chapter 
2). 
4. Furosemide reduces BK-β4 expression and BK-α apical localization in the CNT by 
acidifying the urine, thereby decreasing renal K+ clearance in mice on HK (Chapter 2). 
Taken together, these findings demonstrate how dietary Na+ and K+ intake affect 
furosemide actions on renal K+ handling. On a regular Western diet, furosemide is a K-wasting 
diuretic; while on an alkaline low/normal Na+ high K+ diet, furosemide is a K-sparing diuretic. 
 
Mechanisms for the net K+ secretion in the TAL  
 As discussed in  Chapter 1, Ang II is possibly a critical upstream regulator of the net K+ 
secretion in the TAL by regulating both ROMK and NKCC2 activities. In addition to ROMK and 
NKCC2, the basolateral K+ exit should also play an important role in the net K+ secretion. In 
order for a net K+ secretion, K+ must preferentially exit the apical side. The elevated plasma [K+] 
of mice on LNaHK may have inhibited the basolateral K+ channels. However, the luminal [K+] 
was also elevated to a similar extent. Since ROMK became more active on LNaHK, there must be 
other factors that inhibit the basolateral K+ channels but not the apical ROMK channel.  
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Both a 50-pS (195-197) and an 80-pS (198) K+ channels have been identified in the 
basolateral membrane of both cortical and medullary TAL (cTAL and mTAL). The 80-pS K+ 
channel is activated by vasopressin (199). The 50-pS K+ channel is activated by adenosine (196) 
and Ang II (200) and inhibited by arachidonic acid (195), PGE2 (197), and CaSR activation 
(201) . Although the inhibition of the 50-pS K+ channel by Ang II via AT1 receptor seems 
contradictory to the net K+ secretion in TAL, Ang II may exert the opposite effect via AT2 
receptor on LNaHK, similar to its action on ROMK (157). One study claimed that KCNJ10, the 
major basolateral Kir channel in DCT and CD (202-204), formed the basolateral 40~50-pS K+ 
channel in TAL (205). However, this seems unlikely because this particular study found the 40-
pS KCNJ10 channel only in the distal half of cTAL; while the 50-pS channel has been found in 
both mTAL and cTAL. In addition to K+ channels, one study found a K+-Cl- cotransporter 4 
(KCC4) in the basolateral membrane of TAL (206). Although the KCC4 expression is not 
affected by a high K+ diet (207), the effect of LNaHK remains unclear. 
 
Components involved in the K-sparing effect of furosemide in mice on LNaHK 
Studies from Chapter 1 and Chapter 2 show that furosemide decreases renal K+ clearance 
in mice on both LNaHK and HK through different mechanisms. Comparing the experiments 
between LNaHK + Furo and HK + Furo, a few things are worth noting. 1) Micropuncture 
experiments show a furosemide-sensitive net K+ secretion in the TAL of mice on LNaHK but not 
HK. 2) Furosemide evokes a much greater natriuresis and diuresis in mice on LNaHK than HK. 
3) Furosemide reduces urine pH in mice on both LNaHK and HK. This indicates that there are at 
least three components involved in the furosemide effect on renal K+ handling on LNaHK. In 
mice on LNaHK, furosemide inhibits the net K+ secretion in TAL but increases the K+ secretion 
through ROMK by delivering more Na+ to ASDN. By acidifying the urine, furosemide probably 
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reduces BK-αβ4-mediated K+ secretion as well. The combined effect on the TAL, ROMK and 
BK makes furosemide a K-sparing diuretic in mice on LNaHK. 
 
Mechanisms for furosemide-induced urine acidification 
 The mechanism for furosemide-induced urine acidification seems to be multifactorial. 
The study by Na et. al. (162) showed that chronic furosemide treatment increased the V-ATPase 
expression but did not affect serum aldosterone levels. However, we found an increase in the V-
ATPase expression with elevated aldosterone. The discrepancy may be caused by elevated 
plasma [K+] in furosemide-treated mice on HK. Other studies also showed that furosemide 
increased plasma aldosterone levels probably by activation of RAAS (116, 208, 209). Aside from 
furosemide, elevated plasma AVP could also upregulate V-ATPase activity. Although some 
studies showed that furosemide increased plasma AVP acutely (210, 211), others showed no 
effect during chronic furosemide treatments (211). Another possibility is that furosemide elevated 
plasma Ang II levels (116-118), which has been shown to increase V-ATPase expression in 
unilaterally nephrectomized rats (212). However, aldosterone, AVP, and Ang II are unlikely to 
account for all factors involved in the furosemide-induced urine acidification. According to 
previous studies done by our lab, mice on LNaHK exhibited even higher plasma aldosterone 
levels (around 3600 pg/mL) (99). They should also have elevated AVP and Ang II levels due to 
the low Na+ content of the diet. However, these mice were still able to maintain alkaline urine pH 
above 8.8. One possible explanation is that by inhibiting Na+ reabsorption in TAL, furosemide 
inhibits Ca2+ reabsorption in the TAL as well as DCT and CNT (174, 175). The increased luminal 
[Ca2+] activates CaSR and stimulates V-ATPase activity (176). Additionally, chronic furosemide 
treatment induces hypertrophy of DCT, CNT and CCD (213). The increased V-ATPase 
expression could also be due to the hypertrophy of CNT and increased number of type A 
intercalated cells in response to furosemide treatment (162).  
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Mechanisms for luminal pH regulation of BK-αβ4 channels 
The linear relationship between renal K+ clearance and urine pH agrees with the pH 
sensitivity of CaSR activity (181, 182). This supports our proposed mechanism of BK-αβ4 
regulation by CaSR shown in Figure 27. In mice on HK + Ctrl, the luminal pH in CNT is very 
alkaline, greatly enhancing CaSR activity in the apical membrane. It can increase intracellular 
[Ca2+] to activate BK channels by releasing Ca2+ from ER and increasing Ca2+ reabsorption via 
TRPV5 channels (44). It may also upregulate BK-β4 expression via unknown pathways, possibly 
involving cAMP (214, 215). As a feedback inhibition mechanism, CaSR stimulates V-ATPase 
activity to acidify the lumen (176). In mice on HK + Furo, the lumen in CNT is acidified by 
increased activity of NHE3 and V-ATPase, reducing CaSR activity, which decreases BK channel 
activity and BK-β4 expression. The only known study demonstrating a direct link between CaSR 
and BK channels was in rat bronchopulmonary sensory neurons (216), where CaSR activation 
increased BK currents in cells with low baseline BK activity but slightly inhibited BK currents in 
cells with high baseline BK activity. The relationship between CaSR and BK activation remains 
to be investigated in the kidney. 
  
86 
 
 
Figure 27. Proposed Mechanism of BK-αβ4 regulation by CaSR.  
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One potential flaw of our hypothesis is that urinary Ca2+ excretion is reduced on high K+ 
diets (217-219), for which the mechanism is unclear. Ca2+ are passively reabsorbed by PT and 
TAL via paracellular route but actively reabsorbed in the DCT and CNT transcellularly via 
TRPV5 channels (180, 220, 221). Since Na+ reabsorption in PT and TAL are inhibited on high K+ 
diets (105, 119, 123), it is likely that Ca2+ reabsorption in the DCT and CNT are upregulated by 
high K+ diets. Similar to the thiazide effect on Ca2+ reabsorption, by inhibiting NCC, high K+ diets 
increase Ca2+ reabsorption in DCT by increasing Na+ transport through NCX. However, another 
study showed that CNT played the predominant role for Ca2+ reabsorption (222). In any case, with 
increased Ca2+ sensitivity, the luminal [Ca2+] in DCT2/CNT may be just enough to stimulate 
CaSR to regulate BK-αβ4 channels there. In fact, this provides an explanation why the regulation 
of BK-α localization by pH was only observed in DCT2/CNT but not CD. It may be because after 
increased Ca2+ reabsorption by TRPV5 in DCT2/CNT, the luminal [Ca2+] in CD was not high 
enough to stimulate CaSR to regulate BK-αβ4, leaving BK-α inside the cytoplasm of CD cells. 
Additionally, the relationship between BK and TRPV4 channels has been demonstrated (104). 
High K+ diets increases the expression and apical localization of TRPV4 in the ASDN in an 
aldosterone-dependent manner, which augments the flow-induced TRPV4-mediated Ca2+ entry, 
activating BK channels. TRPV5 channels may also be upregulated by high K+ diets and activate 
BK channels in a similar manner. On the other hand, CaSR may be upstream of the TRPV4-
dependent BK activation since CaSR can activate both TRPV4 and TRPV5 (183, 184). 
Other than CaSR, another potential regulator of BK-αβ4 is the G-protein coupled receptor 
4 (GPR4), which was recently shown to be a pH sensor in the kidney (223, 224). However, GPR4 
is mainly expressed in the endothelial cells of the peritubular capillaries with rather low 
expressions in the epithelial cells (225). One abstract reported GPR4 expression in the basolateral 
membrane of intercalated cells (226). Therefore, GPR4 is unlikely to sense pH from the luminal 
side. Sensitive to extracellular pH, klotho is another possible regulator of BK-αβ4. Studies 
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showed that klotho can increase the activity of TRPV5 in the DCT (227), increasing Ca2+ 
reabsorption, which may lead to BK channel activation. However, klotho shows enhanced 
TRPV5 activity at a lower pH (228), opposite to our finding of the BK-αβ4 channel regulation. 
Other pH sensors in the CNT, such as soluble adenylyl cyclase and the insulin receptor–related 
receptor also sense the pH from the basolateral side and are unlikely to regulate BK-αβ4.  
 
Diets and Diuretics 
Overall, results in this dissertation reflect just a small part of the complicated interactions 
between diets and diuretics. Healthy diets, especially those low in Na+ and high in K, are often 
recommended along with diuretics for hypertensive patients. As shown by the data on furosemide 
and LNaHK, the combination of the two elicited a marked diuretic and natriuretic effect. 
However, extra precautions should be taken to monitor plasma [K+] to avoid devastating 
consequences of hyperkalemia.  
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APPENDIX 
Table 9. Na+ and K+ Contents of the diets used. 
Diet Na+ K+ Anion 
RD 0.3% 0.6% Cl- 
HK 0.3% 5.0% Citrate, Carbonate, Cl- (equal molar) 
HKCl 0.3% 5.0% Cl- 
LNaHK 0.01% 5.0% Citrate, Carbonate, Cl- (equal molar) 
LNaHKCl 0.01% 5.0% Cl- 
 
